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A B S T R A C T
Background
Very early mobilisation (VEM) is performed in some stroke units and recommended in some acute stroke clinical guidelines. However, it is
unclear whether very early mobilisation independently improves outcome after stroke.
Objectives
To determine whether very early mobilisation (started as soon as possible, and no later than 48 hours after onset of symptoms) in people
with acute stroke improves recovery (primarily the proportion of independent survivors) compared with usual care.
Search methods
We searched the Cochrane Stroke Group Trials Register (last searched 31 July 2017). We also systematically searched 19 electronic data-
bases including; CENTRAL; 2017, Issue 7 in the Cochrane Library (searched July 2017), MEDLINE Ovid (1950 to August 2017), Embase Ovid
(1980 to August 2017), CINAHL EBSCO (Cumulative Index to Nursing and Allied Health Literature; 1937 to August 2017) , PsycINFO Ovid (1806
to August 2017), AMED Ovid (Allied and Complementary Medicine Database), SPORTDiscus EBSCO (1830 to August 2017). We searched
relevant ongoing trials and research registers (searched December 2016), the Chinese medical database, Wanfangdata (searched to No-
vember 2016), and reference lists, and contacted researchers in the field.
Selection criteria
Randomised controlled trials (RCTs) of people with acute stroke, comparing an intervention group that started out-of-bed mobilisation
within 48 hours of stroke, and aimed to reduce time-to-first mobilisation, with or without an increase in the amount or frequency (or both)
of mobilisation activities, with usual care, where time-to-first mobilisation was commenced later.
Data collection and analysis
Two review authors independently selected trials, extracted data, assessed risk of bias, and applied the GRADE approach to assess the
quality of the evidence. The primary outcome was death or poor outcome (dependency or institutionalisation) at the end of scheduled
follow-up. Secondary outcomes included death, dependency, institutionalisation, activities of daily living (ADL), extended ADL, quality of
life, walking ability, complications (e.g. deep vein thrombosis), patient mood, and length of hospital stay. We also analysed outcomes at
three-month follow-up.
Main results
We included nine RCTs with 2958 participants; one trial provided most of the information (2104 participants). The median (range) delay to
starting mobilisation after stroke onset was 18.5 (13.1 to 43) hours in the VEM group and 33.3 (22.5 to 71.5) hours in the usual care group.
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The median difference within trials was 12.7 (4 to 45.6) hours. Other differences in intervention varied between trials; in five trials, the VEM
group were also reported to have received more time in therapy, or more mobilisation activity.
Primary outcome data were available for 2542 of 2618 (97.1%) participants randomized and followed up for a median of three months.
VEM probably led to similar or slightly more deaths and participants who had a poor outcome, compared with delayed mobilisation (51%
versus 49%; odds ratio (OR) 1.08, 95% confidence interval (CI) 0.92 to 1.26; P = 0.36; 8 trials; moderate-quality evidence). Death occurred in
7% of participants who received delayed mobilisation, and 8.5% of participants who received VEM (OR 1.27, 95% CI 0.95 to 1.70; P = 0.11;
8 trials, 2570 participants; moderate-quality evidence), and the effects on experiencing any complication were unclear (OR 0.88; 95% CI
0.73 to 1.06; P = 0.18; 7 trials, 2778 participants; low-quality evidence). Analysis using outcomes collected only at three-month follow-up
did not alter the conclusions.
The mean ADL score (measured at end of follow-up, with the 20-point Barthel Index) was higher in those who received VEM compared with
the usual care group (mean difference (MD) 1.94, 95% CI 0.75 to 3.13, P = 0.001; 8 trials, 9 comparisons, 2630/2904 participants (90.6%);
low-quality evidence), but there was substantial heterogeneity (93%). Effect sizes were smaller for outcomes collected at three-month
follow-up, rather than later.
The mean length of stay was shorter in those who received VEM compared with the usual care group (MD -1.44, 95% CI -2.28 to -0.60, P
= 0.0008; 8 trials, 2532/2618 participants (96.7%); low-quality evidence). Confidence in the answer was limited by the variable definitions
of length of stay. The other secondary outcome analyses (institutionalisation, extended activities of daily living, quality of life, walking
ability, patient mood) were limited by lack of data.
Sensitivity analyses by trial quality: none of the outcome conclusions were altered if we restricted analyses to trials with the lowest risk
of bias (based on method of randomization, allocation concealment, completeness of follow-up, and blinding of final assessment), or
information about the amount of mobilisation.
Sensitivity analysis by intervention characteristics: analyses restricted to trials where the mean VEM time-to-first mobilisation was less
than 24 hours, showed an odds of death of 1.35 (95% CI 0.99 to 1.83; P = 0.06; I2 = 25%; 5 trials). Analyses restricted to the trials that clearly
reported a more prolonged out-of-bed activity showed a similar primary outcome (OR 1.14; 0.96 to 1.35; P = 0.13; I2 = 28%; 5 trials), and
odds of death (OR 1.27; 0.93 to 1.73; P = 0.13; I2 = 0%; 4 trials) to the main analysis.
Exploratory network meta-analysis (NMA): we were unable to analyze by the amount of therapy, but low-quality evidence indicated that
time-to-first mobilisation at around 24 hours was associated with the lowest odds of death or poor outcome, compared with earlier or
later mobilisation.
Authors' conclusions
VEM, which usually involved first mobilisation within 24 hours of stroke onset, did not increase the number of people who survived or made
a good recovery after their stroke. VEM may have reduced the length of stay in hospital by about one day, but this was based on low-quality
evidence. Based on the potential hazards reported in the single largest RCT, the sensitivity analysis of trials commencing mobilisation
within 24 hours, and the NMA, there was concern that VEM commencing within 24 hours may carry an increased risk, at least in some
people with stroke. Given the uncertainty around these effect estimates, more detailed research is still required.
P L A I N   L A N G U A G E   S U M M A R Y
Very early versus delayed mobilisation after stroke
Review question
Does very early and active mobilisation improve recovery after stroke compared with more delayed mobilisation?
Background
Care in a stroke unit is recommended for people soon after a stroke, and results in an improved chance of surviving, returning home, and
regaining independence. Very early mobilisation (helping people to get up out of bed very early, and more often after the onset of stroke
symptoms) is performed in some stroke units, and is recommended in many acute stroke clinical guidelines. However, the impact of very
early mobilisation on recovery after stroke is not clear.
Search date
This review is up-to-date to July 2017.
Study characteristics
This review identified nine trials (2958 participants), although one trial (2104 participants) provided most of the information. On average,
very early mobilisation participants started mobilisation 18.5 hours after their stroke, compared with 33.3 hours in the usual care group. In
five trials, the very early mobilisation group were also known to have spent more time per day in therapy, or participated in a mobilisation
activity.
Main results
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Very early mobilisation did not increase the number of people who survived or made a good recovery after their stroke. There was a sug-
gestion that very early mobilisation may reduce the length of stay in hospital by about one day. However, results from the single largest
trial, and from an analysis of trials that started mobilising participants very early, raised the concern that starting intensive mobilisation
within 24 hours of stroke may carry some increased risk, at least for some people with stroke. This potential risk needs to be clarified.
Quality of the evidence
Overall, the main results were supported by moderate-quality evidence overall, but low-quality evidence backed length of hospital stay
and activities of daily living.
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Summary of findings for the main comparison.
Very early mobilisation versus delayed mobilisation
Patient or population: adults with acute stroke
Settings: stroke unit or acute ward
Intervention: very early mobilisation (VEM)
Comparison: delayed mobilisation
Illustrative comparative
risks* (95% CI)
Assumed risk Correspond-
ing risk
Outcomes
Delayed mo-
bilisation
Very early
mobilisation
Relative effect
(95% CI)
No of Partici-
pants
(studies)
Quality of the
evidence
(GRADE)
Comments
Medium risk populationDeath or a poor outcome
(median 3-month follow-up) 486 per 1000 507 per 1000
(465 to 544)
OR 1.08
(0.92 to 1.26)
2542 (8) ⊕⊕⊕⊝
moderate a
Largest trial (2104 participants)
found increased risk of death or
poor outcome with VEM
Medium risk populationDeath
(median 3-month follow-up) 68 per 1000 85 per 1000
(65 to 112)
OR 1.27
(0.95 to 1.70)
2561 (8) ⊕⊕⊕⊝
moderate a
Sensitivity analysis suggested in-
creased risk of death in trials with
earlier onset of VEM
Medium risk populationDeath or dependence (modified Rankin
score 3 to 6; median 3-month follow-up)
486 per 1000 507 per 1000
(465 to 544)
OR 1.08
(0.92 to 1.26)
2542 (8) ⊕⊕⊕⊝
moderate a
Largest trial found increased risk
of death or dependency with VEM
Activities of daily living (ADL)
(Barthel Index score 0 to 20; lower = 0;
median 3-month follow-up)
The mean
Barthel In-
dex scores
across con-
trol groups
ranged from
14.2 to 18.1.
The mean
Barthel Index
score in the
intervention
groups was
on average
1.94 points
MD 1.94 higher
(0.75 to 3.13 high-
er)
2630 (8) ⊕⊕⊝⊝
low a, b
Higher rate of missing data
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higher (0.75
higher to 3.13
higher).
Subjective Health Status score
(Assessment of Quality of Life Score 0 to
1; lower = 0; end of scheduled follow-up)
The mean As-
sessment of
Quality of Life
(AQoL) score
in the con-
trol group was
0.306
The mean
AQoL score
in the inter-
vention group
was on av-
erage 0.07
points higher
(0.1 lower to
0.23 higher)
MD 0.07 higher
(0.1 lower to 0.23
higher)
68 (1) ⊕⊝⊝⊝
very low a, b, c
Higher rate of missing data
Data from one trial only
Medium risk populationAny complication: participants who
experience at least one complication
(median 3-month follow-up)
224 per 1000 200 per 1000
(174 to 234)
OR 0.88
(0.73 to 1.06)
2778 (6) ⊕⊕⊕⊝
low a, c
Uncertain blinding at follow-up
Length of acute hospital stay (days) The mean
length of stay
across con-
trol groups
ranged from
9.8 to 14.9
days.
The mean
length of
stay in the in-
tervention
groups was,
on average,
1.44 days
less (2.28
days less to
0.60 day less)
MD 1.44 lower
(2.28 lower to 0.60
lower)
2551 (8) ⊕⊕⊝⊝
low a, b
Different definitions and impre-
cise measures of length of stay
were reported
Result largely depends on two
small trials with small SDs
*The basis for the assumed risk (e.g. the mean control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based
on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; OR: odds ratio; MD: mean difference
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
a Downgraded for potential risk of performance bias.
b Downgraded for unexplained heterogeneity.
c Downgraded for imprecision.
 
Cochrane
Library
Trusted evidence.
Inform
ed decisions.
Better health.
  
Cochrane Database of System
atic Review
s
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
B A C K G R O U N D
Description of the condition
Stroke presents a major global public health challenge, with over
five million people dying from stroke each year, and many more liv-
ing with chronic disability (Murray 2012). We know that treatment
in an organised multidisciplinary stroke unit (compared with treat-
ment in a general medical ward) reduces the odds of being dead or
disabled at 12 months post stroke (SUTC 2013). However, relatively
little is known about which components of acute stroke unit care
may be responsible for better outcomes (Langhorne 2012). Early re-
habilitation (in particular early mobilisation) is described as an im-
portant feature of stroke unit care, but there is only limited infor-
mation about what early rehabilitation entails and who provides it
(Langhorne 2012). In addition to the uncertainties surrounding the
optimal amount of rehabilitation that can be provided early after
stroke, exactly how early rehabilitation should start is controver-
sial.
Description of the intervention
Early mobilisation (getting people up and out of bed and sitting,
standing, and walking early after stroke) is an established feature
of acute stroke unit care, particularly in many Scandinavian hos-
pitals (Indredavik 1999). In other parts of the world, patients may
be restricted to bed for some days before mobilisation is allowed
(Diserens 2006). In some cases, these differences in practice reflect
concerns about the possibility that early mobilisation may have
a detrimental effect on the vulnerable ischaemic penumbra (Dis-
erens 2006), although there is little evidence to support this view
(Bernhardt 2007; Bernhardt 2015), while in other cases, they are
likely to reflect historical practices.
How the intervention might work
The biological rationale for early mobilisation is based on three
lines of argument: 1) there is evidence that bedrest has a harm-
ful impact across many conditions, and is likely to slow recovery
(Allen 1999; Mutin-Carino 2014); 2) some of the most common and
serious complications after stroke are those related to immobili-
ty (Langhorne 2000); and 3) current concepts of biological recov-
ery after brain injury suggest a narrow window of opportunity for
brain plasticity and repair (Murphy 2009). We know that the rou-
tine day of most acute stroke patients is largely inactive, so intro-
ducing frequent training out of bed could reduce the risk of com-
plications of immobility (Bernhardt 2004; Bernhardt 2015). Also, if
the brain does indeed remodel itself based on experience (Johans-
son 2000; Krakauer 2012), then early task-specific training may well
contribute to improving recovery (Pekna 2012).
However, there are also concerns about potential harm of early
mobilisation, particularly in the first 24 hours after stroke onset
(Bernhardt 2004; Skarin 2011). These concerns include haemody-
namic considerations: whether raising the person's head early af-
ter stroke will impair cerebral blood flow and cerebral perfusion
(Skarin 2011). Alternatively, in the case of intracerebral haemor-
rhage, whether early mobilisation will increase the risk of inducing
further bleeding (Olavarria 2014). As a result of these theoretical
concerns, some clinicians have advocated initial bedrest for peo-
ple with stroke (Skarin 2011). This uncertainty about the best ap-
proach stimulated a large cluster-randomised trial that explored
the impact of head postioning in people with acute stroke (Muñoz-
Venturelli 2015). This trial found no clear difference in outcomes for
people nursed flat for the first 24 hours after stroke versus those
nursed with their head up, and allowed to mobilise to the toilet (An-
derson 2017).
Why it is important to do this review
Although very early mobilisation (VEM) has been recommended in a
number of acute stroke clinical guidelines (Adams 2003; Bernhardt
2015; NSF 2007), only indirect evidence currently supports these
recommendations (Indredavik 1999). It is not known whether VEM
independently improves outcome after stroke.
O B J E C T I V E S
To determine whether very early mobilisation (started as soon as
possible, and no later than 48 hours after onset of symptoms) in
people with acute stroke improves recovery (primarily the propor-
tion of independent survivors) compared with usual care.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We sought all randomized trials, with or without blinding, of VEM
within 48 hours of symptom onset compared with more delayed,
usual care (i.e. normal practice or no routine intervention).
Types of participants
Participants in trials had to be adults with a definite clinical diag-
nosis of stroke (focal neurological deficit of cerebrovascular origin),
and could be mobilised within 48 hours of stroke onset. There were
no age restrictions.
Types of interventions
We defined VEM as any intervention delivered with the aim of re-
ducing the time from stroke onset to first mobilisation (first out-of-
bed episode), which may have included increasing the amount of
out-of-bed physical activity (e.g. participation in activities of dai-
ly living (ADLs), such as walking to the toilet, transferring on and
oH the toilet, sitting out of bed, standing, and walking). Any form
of VEM was considered, regardless of the number and discipline of
staH assisting, and the dose or duration of the intervention. We de-
fined usual care as the usual mobilisation practice.
Types of outcome measures
The aim was to identify all outcomes of interest at the end of
scheduled follow-up, and also (where available) at three-month fol-
low-up.
Primary outcomes
Death or a poor outcome: the number of participants who died
or had a poor outcome at the end of scheduled follow-up (in pre-
ferred order, this was defined as: remained dependent (modified
Rankin Score (mRS) 3 to 5, or Barthel score < 15, or equivalent), or
required admission to institutional care. We defined institutional
care as care provided in a residential home, nursing home, or hos-
pital at follow-up.
Secondary outcomes• Death: number of deaths from any cause
Very early versus delayed mobilisation aer stroke (Review)
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• Death or dependence: the number of participants dead or phys-
ically dependent (mRS 3 to 5, or equivalent)• Death or requiring institutional care: we defined institutional
care as care provided in a residential home, nursing home, or
hospital at follow-up.• Performance in activities of daily living (ADL): using a recognised
ADL score• Performance in extended activities of daily living (community
and domestic activities): using a recognised extended ADL score• Patient subjective health status or quality of life score• Ability to walk: walking unassisted (without help from another
person), reported alone, or as a component of a functional mo-
bility scale• Mobility score: using a recognised mobility score• Complications (adverse events): number or severity (or both) of
complications (adverse events), including deep vein thrombosis
(DVT), pulmonary embolism (PE), incidence and grade of pres-
sure sores (using standardized grading scale), number of incon-
tinent episodes over 24 hours, severity of incontinence, chest in-
fection, falls, and physiological variables (blood pressure, oxy-
gen, temperature) recorded• Type of complication (adverse events): categorised as compli-
cations of immobility (DVT, PE, incidence and grade of pressure
sores (using standardized grading scale), chest infection, urinary
tract infection, falls), and other complications• Patient mood: using a recognised measure of mood• Length of stay in acute hospital (recorded in days)
Search methods for identification of studies
See the Cochrane Stroke Group Trials Register. We aimed to identify
all relevant RCTs, regardless of language or publication status (pub-
lished, unpublished, in press, or in progress). We arranged transla-
tion of relevant articles where required.
Electronic searches
We searched the Cochrane Stroke Group Trials Register, which was
last searched by the Cochrane Stroke Group Information Specialist
on 31 July 2017. In addition, we systematically searched the follow-
ing electronic databases.
• Cochrane Central Register of Controlled Trials (CENTRAL; 2017,
Issue 7) in the Cochrane Library (searched August 2017; Appendix
1);• MEDLINE Ovid (1950 to August 2017; Appendix 2);• Embase Ovid (1980 to August 2017; Appendix 3);• CINAHL EBSCO (Cumulative Index to Nursing and Allied Health
Literature; 1937 to August 2017; Appendix 4);• PsycINFO Ovid (1806 to August 2017; Appendix 5);• AMED Ovid (Allied and Complementary Medicine Database; 1985
to August 2017; Appendix 6);• SPORTDiscus EBSCO (1830 to August 2017; Appendix 7);• Science Citation Index Expanded (1900 to August 2017; Appen-
dix 8);• Social Sciences Citation Index (1956 to August 2017);• Arts and Humanities Citation Index (1975 to August 2017);• PEDro (Physiotherapy Evidence Database (www.pedro.fhs.usy-
d.edu.au/; 1929 to December 2006);
• REHABDATA (National Rehabilitation Information Centre
(www.naric.com/?q=en/REHABDATA; 1956 to November 2016);• CIRRIE (Center for International Rehabilitation Research Infor-
mation and Exchange (cirrie.buffalo.edu/; 1990 to November
2016);• OTSeeker (searched to November 2016);• Wan Fang Database (www.wanfangdata.com/; searched to No-
vember 2016);• British Association of Occupational Therapists’ Library Collec-
tion (including Thesis Collection; searched to November 2016);• ProQuest Dissertations and Theses — Global (formerly Index to
UK Theses; searched to November 2016).
We used the search strategy for MEDLINE, and with the assistance
of the Cochrane Stroke Group Information Specialist, modified it to
suit other databases (Appendix 2).
We searched the following ongoing trials and research registers.
• US National Institutes of Health Ongoing Trials Register Clinical-
Trials.gov (ClinicalTrials.gov; searched December 2016);• World Health Organization (WHO) International Clinical Trials
Registry Platform (ICTRP'; apps.who.int/trialsearch; searched
December 2016);• ISRCTN Registry (www.isrctn.com; formerly the Meta Register
of Controlled Trials (mRCT): www.controlled-trials.com/mrct/;
searched December 2016);• UK Department of Health Research Findings Register (ReFeR
and latterly www.isrctn.com/).
Searching other resources• We originally handsearched all available years of the following
journals (these were not updated after 2006 in view of the in-
creased sensitivity of our other search strategies).* Advances in Occupational Medicine and Rehabilitation (1996
to 1999);* Advances in Clinical Neurosciences and Rehabilitation (2001 to
2006);* Advances in Clinical Rehabilitation (1987 to 1990);* Archives of Occupational Therapy (renamed Occupational
Therapy and Rehabilitation; 1922 to 2006);* Canadian Journal of Rehabilitation (1987 to 1999);* Chinese Journal of Physical Medicine and Rehabilitation (1980
to 2006);* European Journal of Physical Medicine and Rehabilitation
(1991 to 1999);* International Journal of Rehabilitation and Health (1995 to
2000);* Journal of Rehabilitation Administration (1987 to 2006);* Rehabilitation (1948 to 1949, 1951 to 1977);* Rehabilitation in Canada (1963 to 1972);* Rehabilitation Nursing Research (1992 to 1996);* Topics in Stroke Rehabilitation (1995 to 2006).• We sought information about unpublished or incomplete trials
via correspondence with researchers or organisations (or both),
known to be involved in previous relevant studies.• We checked the bibliographies of included studies and relevant
reviews for further references to additional relevant trials.
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Data collection and analysis
Selection of studies
We selected trials for inclusion based on the described inclusion cri-
teria. For this update, one review author (PL) read all the references
identified and eliminated any obviously irrelevant studies. Two re-
view authors (selected from MT, JMC, PL, JB, TB) independently
read the titles (and abstracts if available) of the identified refer-
ences. We obtained the full text for remaining studies, and based on
the inclusion criteria (types of studies, types of participants, aims
of interventions, outcome measures), two review authors (selected
from MT, JMC, PL, JB, TB) independently classified these as eligible,
not eligible, or unsure. We excluded any trials that both review au-
thors classified as not eligible. At least two review authors (select-
ed from MT, JMC, PL, JB, TB) independently made decisions about
inclusion, and we resolved differences in opinion regarding trial el-
igibility by discussion between all review authors. If further infor-
mation was needed to reach consensus, we contacted trialists, and
attempted to obtain the missing information. We arranged trial se-
lection decisions to avoid trialists making decisions about trials in
which they were involved.
Papers and abstracts in Chinese were reviewed by one researcher
fluent in Chinese and with medical training (YL, JW, or WZ, see Ac-
knowledgements). One review author (MT or PL) assessed a short
English description of the decision made.
Data extraction and management
Our primary aim was to obtain standardized data through collabo-
ration with the original trialists. Two review authors (from MT, JMC,
PL, TB) independently extracted data from published sources, us-
ing a standard data recording form. We extracted important risk of
bias indicator data such as concealment of randomization, blinding
of outcome evaluation, and intention-to-treat analysis, and grad-
ed these as present, absent, or unclear. In addition, we extracted
data relating to all primary and secondary outcomes of interest,
as well as important imbalances in prognostic factors, comparison
(details of the intervention in the treatment and control groups, de-
tails of co-intervention(s) in both groups), and other relevant out-
comes not prespecified in the protocol (for example, exertion).
The review authors checked all the extracted data for agreement; a
third review author arbitrated any items where they could not reach
consensus. If necessary, we contacted trialists to request more in-
formation, clarification, or missing data.
Assessment of risk of bias in included studies
Two review authors (from PL, MT or TB), who had no involvement in
the study under review, independently evaluated the risk of bias of
included trials, using the Cochrane 'Risk of bias' tool, and extracted
information for each included trial about the method of random-
ization and allocation concealment, blinding of outcome assess-
ment, and any intention-to-treat analyses. We applied the GRADE
approach to assess the quality of the evidence (Higgins 2011).
Measures of treatment e?ect
We compared interventions that commenced mobilisation earlier
and aimed to improve the frequency or amount (or both) of mobil-
isation activity, delivered by any member of the acute stroke unit
staH, versus more delayed mobilisation (usual care) on primary and
secondary outcome measures. We analysed binary (dichotomous)
outcomes with a fixed-effect model, as odd ratios (OR) with 95%
confidence intervals (CI). For continuous outcomes, we calculated
a mean difference (MD) with a random-effects model, to take ac-
count of any statistical heterogeneity. We used the standardized
mean difference (SMD) where different scales were used for the
same outcome.
Unit of analysis issues
We only included randomized parallel group trials, in which the unit
of analysis was the individual participant. We did not include clus-
ter- or cross-over RCTs.
Dealing with missing data
We assessed the degree of missing data for each of the main out-
comes and had planned to conduct sensitivity analyses if more
than 15% of randomized participant data were missing.
Assessment of heterogeneity
We examined the statistical heterogeneity between studies using
the I2 statistic. We determined substantial heterogeneity as a value
greater than 50%.
Assessment of reporting biases
We had planned to carry out funnel plots if more that 10 trials were
available.
Data synthesis
If continuous data were only available as medians and interquartile
ranges, we estimated the mean using an established method (Wan
2014). Where only interquartile ranges (IQR) were reported, we in-
ferred the standard deviation as follows: the IQR will incorporate
50% of the distribution of data compared with standard deviation,
which can be expected to include 70% (± 35%) of the distribution.
Therefore, assuming a normal distribution, one standard deviation
should equal the IQR/(2 x 0.7). We used the Cochrane Review Man-
ager 5 software for analyses (RevMan 2014).
Subgroup analysis and investigation of heterogeneity
We did not plan subgroup analyses for this version of the review,
which did not have individual patient data available. We planned
to explore heterogeneity through sensitivity analyses.
Sensitivity analysis
We conducted sensitivity analyses to evaluate the effect of differ-
ences in methodological quality (method of randomization, allo-
cation concealment, intention-to-treat analysis, and blinding of fi-
nal assessment), time-to-first mobilisation, and amount of mobili-
sation activity.
Network meta-analysis
In view of new approaches to meta-analysis, we also included a
post-hoc network meta-analysis (NMA) of trial data. This review
aimed to include trials that compared the effect of a shorter time-
to-first mobilisation (with or without an increase in the amount
or frequency (or both) of mobilisation activities) with usual care
(where time-to-first mobilisation started later). However, we ex-
pected that within this broad definition, the included trials would
comprise a range of treatment comparisons. Therefore, we includ-
ed an exploratory NMA to explore, where possible, the impact of
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different treatment characteristics (time-to-first mobilisation and
amount of mobilisation activity). We used Metainsight software,
designed specifically for this role, to conduct our NMA (https://cr-
su.shinyapps.io/metainsightb/).
A NMA uses information from both direct and indirect estimates
of treatment effect (Tonin 2017). Direct estimates are provided by
a head-to-head comparison (e.g. treatment A versus treatment B).
Indirect estimates are provided by two or more head-to-head com-
parisons that share a common comparator (e.g. when A verus B is
the comparison of interest, then use trials with A versus C and with
B versus C). A network is then formed, using a collection of trials
that allow, through direct and indirect comparisons, calculation of
the relative effects of all treatments versus each other (or versus a
single comparator).
A key assumption in NMA is the transitivity (or similarity) assump-
tion that concerns the validity of making indirect comparisons. This
assumes that treatment effects are 'exchangeable’ across the in-
cluded trials and all treatments are 'jointly randomisable'. In oth-
er words, all treatment categories could feasibly be randomized in
the same trial and those that are not treatment arms in any given
trial are 'missing at random' (Lu 2006). This assumption cannot be
formally tested statistically, and it must be judged through care-
ful consideration of the trial settings and characteristics, treatment
mechanisms, and participant demographics to investigate if any
differences would be expected to modify relative treatment effects.
A second key assumption (known as the consistency assumption)
assumes that it is feasible to make indirect comparisons between
two treatments, and that the indirect evidence is consistent with
the direct evidence, where such a comparison exists (Lu 2006). The
consistency assumption is evaluated statistically by comparing the
difference between the direct and the indirect estimate for each
loop of evidence. Therefore, we examined for any important differ-
ences in numerical results between direct, indirect, and network
results.
Assessing the quality of the evidence
NMA presents challenges when grading the quality of evidence. We
used the approach of the GRADE group as follows (Puhan 2014).
• Present direct and indirect treatment estimates for each com-
parison of the evidence network.• Rate the quality of each direct and indirect effect estimate
(downgrading for risk of bias, inconsistency, indirectness, im-
precision, and publication bias).• Present the NMA estimate for each comparison of the evidence
network.• Rate the quality of each NMA effect estimate (as above).
R E S U L T S
Description of studies
Please see Characteristics of included studies, Characteristics of
ongoing studies, Characteristics of studies awaiting classification
and Characteristics of excluded studies.
Results of the search
The collated searches from this, and the previous version of the re-
view, identified 21,395 titles (Bernhardt 2009; Figure 1). The origi-
nal version of the review identified a total of 39 trials of interest by
September 2007, 28 of which we excluded; 10 were ongoing or un-
classified, and one was included (AVERT II 2008).
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Figure 1.   Study flow diagram
 
 
Very early versus delayed mobilisation aer stroke (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
10
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Figure 1.   (Continued)
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This update identified a total of 74 studies of interest, 53 of which
we excluded for various reasons, as detailed in the 'Characteristics
of excluded studies' table.
In addition to the excluded studies, there are eight studies for which
we have been unable to obtain full references and for which we
have been unsuccessful in obtaining any further information from
the authors, therefore they are still awaiting classification (Izumi
2001; Liu 2010e; Nilsson 2003; Skevin 2009; Song 2010; Xu 2001;
Zheng 2004a; Zielke 2003). Three trials are currently ongoing, with
no available data (ChiCTR-ICR-15005992; ChiCTR-IPR-16008652;
ChiCTR-TRC-08000201). They plan to recruit about 400 participants
in total. One trial is in the development stage (AVERT-DOSE 2017).
Details of these trials are reported in the 'Characteristics of ongoing
studies' table.
Included studies
We included nine trials in the review (AVERT II 2008; AVERT III 2015;
Chippala 2015a; Chippala 2015b; Langhorne 2010; Morreale 2016;
Poletto 2015; SEVEL 2016; Sundseth 2012). Note that the 'Charac-
teristics of included studies' table contains 11 items, because one
trial contained two arms (Morreale 2016), which for some analyses
had to be analysed separately (Morreale 2016 CTE; Morreale 2016
PNF).
The nine included trials had a total of 2958 participants; the inclu-
sion and exclusion criteria are shown in the 'Characteristics of in-
cluded studies' table. The included participants were broadly rep-
resentative of the stroke population, although the numbers were
dominated by one multicentre trial of 2104 participants (AVERT
III 2015). Across all nine included trials, the mean age of partici-
pants within each trial ranged from 60 to 77 years (median 68),
and the proportion of males ranged from 35% to 72% (median
52%). Stroke severity was measured using the National Institutes of
Health Stroke Scale (NIHSS), and usually classified as mild (NIHSS 0
to 7), moderate (NIHSS 8 to 16), or severe (NIHSS > 16) stroke (Brott
1989). The baseline stroke severity was typically in the moderate
range, with the proportion with intracerebral haemorrhage ranging
from 0% to 20% (median 12%).
We did not observe imbalances between groups in important prog-
nostic factors, including age, stroke severity, type of stroke, and
premorbid disability.
We categorised the intervention details using the TIDieR classifi-
cation, which are summarized in the 'Characteristics of included
studies' table (Hoffman 2014). The interventions were delivered in
a stroke unit (AVERT II 2008; AVERT III 2015; Chippala 2015a; Chip-
pala 2015b; Langhorne 2010; Poletto 2015; Sundseth 2012), stroke
centre ( SEVEL 2016), or neurology ward (Morreale 2016). The very
early mobilisation (VEM) intervention was provided by physiother-
apy, with or without nursing staH, and continued while the partici-
pant was in hospital. The nine trials all tested different versions of
a VEM strategy as follows.
Earlier onset
In six trials, intervention participants were mobilised within 24
hours of stroke (AVERT II 2008; AVERT III 2015; Chippala 2015a; Chip-
pala 2015b; Morreale 2016; Sundseth 2012), while in three, this usu-
ally occurred at 24 to 48 hours (Langhorne 2010; Poletto 2015; SEV-
EL 2016). Across all trials, the median (range) delay to starting mo-
bilisation after stroke was 18.5 (13.1 to 43) hours in the VEM group,
and 33.3 (22.5 to 71.5) hours in the usual care group. The median
difference (range) within trials was 12.7 (4 to 45.6) hours.
More intensive
In four trials, VEM included a recorded increase in time of out-of-
bed mobility activities (AVERT II 2008; AVERT III 2015; Langhorne
2010; Poletto 2015). One trial reported a longer time participants
were recorded sitting out of bed, but not a very active mobilisation
activity (SEVEL 2016). One trial reported a similar intensity (Sund-
seth 2012), but information was more limited from three others
(Chippala 2015a; Chippala 2015b; Morreale 2016).
Modifiable intervention
Five trials reported that the intervention could be modified or
stopped in the event of a deterioration in the participant's physio-
logical or neurological status (AVERT II 2008; AVERT III 2015; Lang-
horne 2010; SEVEL 2016; Sundseth 2012). Information was more
limited from four others (Chippala 2015a; Chippala 2015b; Morreale
2016; Poletto 2015).
Monitored intervention
In several trials, the difference in care delivered was timed and
recorded. Five trials recorded an earlier onset of mobilisation with
an increased number of minutes of out-of-bed activity (AVERT II
2008; AVERT III 2015; Langhorne 2010; Poletto 2015; SEVEL 2016).
Three trials recorded an earlier onset of mobilisation, but no report-
ed difference in activity (Chippala 2015a; Chippala 2015b; Sundseth
2012). We had limited information from one other trial (Morreale
2016).
Excluded studies
We excluded a total of 53 studies (AMOBES 2017; Asberg 1989;
Chu 2003; Di Lauro 2003; Diserens 2010; Duan 2006; Fang 2001a;
Fang 2001b; Gong 2003; Gorbunov 2003; Gu 2006; Guan 2001; Ham-
rin 1982; Hara 2001; Huang 2001; Huang 2003; Ishida 2001; Kreisel
2005; Li 1999; Li 2003; Li 2004; Lin 2005; Liu 2001b;Liu 2003b; Liu
2004; Marshall 2011; Miskovic 2004; Pan 2004; Qian 2003;Qian 2004;
Raicevic 2000; Richards 1993; Sankara Kumaran 2013; Song 2005;
Sun 2002; Toyota 2001; Truscott 1974; Wang 2004; Wang 2005;
Wang 2006; Wu 2012; Xi 2003; Xiao 2000; Xiao 2004; Xie 2003a; Xue
2004; Xue 2006; Xue 2008; Zeng 2004; Zhang 1998; Zhang 2001; Zhao
2003; Zheng 2004; Zheng 2004a; Zielke 2003). Many of these studies
were published in Chinese language journals and required transla-
tion to English. We excluded these trials for various reasons, as de-
tailed in the 'Characteristics of excluded studies' table. The main
reasons for exclusion were late intervention, not early mobilisation
intervention, timing not stated, and not randomized.
Risk of bias in included studies
The risk of bias assessments are summarized in the Characteristics
of included studies, and in Figure 2 and Figure 3.
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Figure 2.   Risk of bias summary: review authors' judgements about each risk of bias item for each included study
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Figure 2.   (Continued)
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Figure 3.   Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages
across all included studies
 
Allocation
All trials reported using a computer-generated randomization
schedule. Allocation was concealed by using sequential, opaque
envelopes, or a secure, centralised randomization procedure.
We assessed random sequence generation to be at low risk of bias
for eight studies, and unclear for one study (Chippala 2015b).
We assessed allocation concealment to be at low risk of bias for
eight studies, and unclear for one study (Morreale 2016).
Blinding
Blinding of treating therapists and patients was challenging. In
three trials, the treating staH were aware of the VEM protocol, but
this was masked from the rest of the staH (AVERT II 2008; AVERT III
2015; Langhorne 2010). Patients were aware they were in a trial of
different protocols, but the details were not emphasised. Blinding
was uncertain for the other trials. We assessed blinding to be at low
risk of bias for two studies (AVERT II 2008; AVERT III 2015), at unclear
risk for three studies (Langhorne 2010; SEVEL 2016; Sundseth 2012),
and at high risk for four studies (Chippala 2015a; Chippala 2015b;
Morreale 2016; Poletto 2015).
All but one trial used an independent (blinded) assessor for the fol-
low up of the primary outcome (SEVEL 2016). The security of blind-
ing was less complete for secondary outcomes, such as in hospital
complications.
Incomplete outcome data
Intention-to-treat analyses were not possible with incomplete out-
come data. Therefore incomplete data were described for each out-
come analysis. We assessed the risk of bias to be low in five stud-
ies (AVERT II 2008; AVERT III 2015; Chippala 2015a; Chippala 2015b;
Langhorne 2010); unclear in two studies (Morreale 2016; Sundseth
2012); and high in two studies (Poletto 2015; SEVEL 2016).
Selective reporting
Reporting was largely complete for the primary outcome; nine trials
included the primary outcome of death or dependence (mRS score
3 to 5) at three months post stroke, although one did not report this
as dichotomous data (Morreale 2016). Data were available for 2542
of 2618 (97.1%) participants randomized, and followed up for a me-
dian of three months. In addition, three trials also planned or con-
ducted follow-up at one year (AVERT II 2008; AVERT III 2015; Mor-
reale 2016).
Data were less complete for the secondary outcome measures,
which were usually conducted at three months. This was probably
due to missing data (rather than selective reporting) when partic-
ipants had to actively complete a score. These outcomes includ-
ed: ADL score, extended ADL score, subjective health status, mood
score, mobility, place of residence, presence and type of compli-
cations. Complications were usually recorded during the period of
hospitalisation, and were divided into: 1) complications of immo-
bility (chest infection, urinary infection, pulmonary thromboem-
bolism, pressure sores), plus 2) others. Specific comments were
made for each outcome listed in the 'Summary of findings' table
(Summary of findings for the main comparison).
We do not presently have sufficient data for the planned subdi-
vision of other complications into neurological causes (recurrent
stroke, seizure, progressing stroke - defined according to the Euro-
pean Progressing Stroke Study definition (Barber 2004), or a pro-
gressive deterioration in the Scandinavian Stroke Scale or National
Institutes of Health Stroke Scale).
Other potential sources of bias
Several of the review authors are trialists in this area and have pub-
lications included in this review. However, we arranged trial selec-
tion decisions to avoid trialists making decisions about their own
trials.
E?ects of interventions
See: Summary of findings for the main comparison
Very early versus delayed mobilisation aer stroke (Review)
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Primary outcome
Death or a poor outcome
Data were available from all trials, except Morreale 2016, for the
outcome of death or a poor outcome, at the end of scheduled fol-
low-up. Within these eight trials, data were available for 2542 of
2618 participants randomized (97.1%). The number of participants
dying or having a poor outcome at the end of scheduled follow-up
was similar in those who received VEM (640/1262, 50.7%) to those
in the usual care group (622/1280, 48.6%; odds ratio (OR) 1.08, 95%
confidence interval (CI) 0.92 to 1.26; P = 0.36; Analysis 1.1; moder-
ate-quality evidence)). There was substantial heterogeneity (68%);
reanalysis with a random-effects model did not alter the conclu-
sions (fixed effect OR 1.08, 95% CI 0.92 to 1.26; random effects OR
0.77, 95% CI 0.45 to 1.31).
Analysis using outcomes collected at three-month follow-up did
not alter the conclusions. It is notable that the original pre-planned
analysis of the largest trial, which contributed 2104 of the total of
2618 (80%) participants included, found increased odds of death
or poor outcome (mRS 3 to 6) at three months, after adjustment
for prognostic factors (adjusted OR 1.37, 95% CI 1.11 to 1.69; P =
0.004; unadjusted OR 1.17, 95% CI 0.99 to 1.39; P = 0·06; Analysis
2.1; AVERT III 2015).
Secondary outcomes
Death
Data were available from all trials, except Morreale 2016, for the
outcome of death, at the end of scheduled follow-up. Within these
eight trials, data were available for 2561 of 2618 participants ran-
domized (97.8%). There was no statistically significant difference
in the number of deaths at the end of scheduled follow-up among
those who received VEM (108/1274, 8.5%) compared with the con-
trol group (87/1287, 6.8%; OR 1.27, 95% CI 0.95 to 1.70; P = 0.11;
Analysis 1.2; moderate-quality evidence). There was little hetero-
geneity (0%). Analysis using outcomes collected at three-month
follow-up did not alter the conclusions (Analysis 2.2).
Death or dependence
Data were available from all trials, except Morreale 2016, for the
outcome of death or dependence (mRS 3 to 6), at the end of sched-
uled follow-up. Within these eight trials, data were available for
2542 of 2618 participants randomized (97.1%). There was no clear
difference in the risk of participants dying or remaining depen-
dent in those who received VEM (640/1262, 50.7%) compared with
the control group (622/1280, 48.6%) at the end of scheduled fol-
low-up (OR 1.08, 95% CI 0.92 to 1.26, P = 0.36; Analysis 1.3; moder-
ate-quality evidence). There was substantial heterogeneity (68%).
Re-analysis with a random-effects model did not alter the conclu-
sions. Analysis using outcomes collected at three-month follow-up
did not alter the conclusions (Analysis 2.3).
Please note that because we had access to our preferred depen-
dence data for the primary (poor) outcome (Analysis 1.1 and Analy-
sis 2.1), the death or dependence outcomes (Analysis 1.3 and Analy-
sis 2.3) were identical to the primary outcome.
Death or institutional care at end of scheduled follow-up
Data were available from only three trials for the outcome of death
or requiring institutional care, at the end of scheduled follow-up
(AVERT II 2008; Langhorne 2010; SEVEL 2016). Overall data were
available for only 227 of 270 participants randomized (84.1%).
There was no clear difference in the risk of participants dying or
requiring institutional care at the end of scheduled follow-up in
those who received VEM (21/112, 18.8%) compared with the control
group (20/115, 17.4%; OR 1.05, 95% CI 0.53 to 2.07, P = 0.89; Analysis
1.4). There was little heterogeneity (20%). Analysis using outcomes
collected at three-month follow-up did not alter the conclusions
(Analysis 2.4).
Performance in activities of daily living
Data were available from all trials, except Chippala 2015b, for the
outcome of activities of daily living (ADL) score, at the end of sched-
uled follow-up. All trials used the Barthel Index, so we convert-
ed scores to a standard scale of 0 to 20. Overall, data were avail-
able for 2630 of 2909 participants randomized (90.6%). There was
a higher mean ADL score for those who received VEM, compared
with the control group (mean difference (MD) 1.94, 95% CI 0.75 to
3.13; P = 0.001; Analysis 1.5; low-quality evidence). There was sub-
stantial heterogeneity (93%), so we completed the analysis using
a random-effects model. Cautious interpretation is also required,
because the Barthel Index often has a non-normal distribution.
Most trials included terminal follow-up at three months, so many
of the data are the same in both analyses. Analysis using outcomes
collected at three-month follow-up resulted in a smaller observed
effect size (MD 0.75, 95% CI 0.01 to 1.49; P = 0.05; Analysis 2.5); low-
quality evidence) and a lesser degree, although still substantial, of
heterogeneity (80%), so we used a random-effects model for analy-
sis.
Performance in extended activities of daily living (community
and domestic activities)
No data were available for this outcome.
Patient subjective health status and quality of life
Only AVERT II 2008 reported this outcome in the form of the Assess-
ment of Quality of Life scale. They found no significant difference
between groups (MD 0.07, 95% CI -0.10 to 0.23; P = 0.42; 1 trial, 68
participants; Analysis 1.6; very low-quality evidence).
Able to walk and mobility score
Data were available from four trials for the outcome of being able
to walk at follow-up (AVERT II 2008; AVERT III 2015; Langhorne 2010;
Sundseth 2012). Within these four trials, data were available for
2255 of 2272 participants randomized (99.3%). There was no clear
difference in the number of participants able to walk among those
who received VEM (831/1130, 73.5%) compared with the control
group (827/1125, 73.5%) at follow-up (OR 1.00, 95% CI 0.83 to 1.21;
P = 0.99; Analysis 1.7). There was substantial heterogeneity (60%),
but re-analysis with a random-effects model did not alter the con-
clusions.
Data were available from only two trials for the outcome of mobil-
ity score at the end of scheduled follow-up (AVERT II 2008; Lang-
horne 2010). Within these two trials, data were available for 102 of
103 participants randomized (99.0%). There was no significant dif-
ference in the mean score between those who received VEM com-
pared with the control group (standardized mean difference (SMD)
0.14, 95% CI -0.27 to 0.56; P = 0.50; Analysis 1.8). There was no sub-
stantial heterogeneity (8%).
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Complications: any complication
Data were available from all trials, except Chippala 2015a, Chip-
pala 2015b, and SEVEL 2016, for the outcome of participants who
reported any complication, recorded at follow-up. Within these six
trials, data were available for 2778 of 2818 participants random-
ized (98.6%). There was no statistically significant difference in the
risk of participants developing a complication among those who
received VEM (287/1436, 20.0%) compared with the control group
(301/1342, 22.4%) at the end of scheduled follow-up (OR 0.88, 95%
CI 0.73 to 1.06; P = 0.18; Analysis 1.9; low-quality evidence). There
was no substantial heterogeneity (0%).
When complications were divided into those classified as compli-
cations of immobility and other complications, there was no signif-
icant difference between groups (test for subgroup differences P =
0.23; Analysis 1.10). We had insufficient information to analyze by
severity of complication, or other types of complication.
Patient mood at the end of scheduled follow-up
Only two trials reported this outcome (AVERT II 2008; Sundseth
2012). There was no significant difference between groups (SMD
0.07, 95% CI -0.33 to 0.46; P = 0.74; 2 trials, 100 participants; Analy-
sis 1.11).
Length of stay in acute hospital
Data were available from all trials, except Morreale 2016, for the
outcome of length of acute stay in hospital. Within these eight tri-
als, data were available for 2551 of 2618 participants randomized
(97.4%). Seven of the eight trials reported a shorter length of stay in
the VEM group. Across all trials, there was a shorter mean length of
stay for the group who received VEM compared with the usual care
group (MD -1.44, 95% CI -2.28 to -0.60; P = 0.0008; Analysis 1.12; low-
quality evidence). There was no substantial heterogeneity (26%),
but we completed the analysis using a random-effects model, be-
cause of the variable definitions of length of stay. This result was
largely driven by two small trials, with narrow standard deviation
values (Chippala 2015a; Chippala 2015b). Cautious interpretation
is also required because the length of stay often has a non-normal
distribution.
Sensitivity analysis
Trial quality: none of the outcome conclusions were altered if we
restricted analysis to trials with the highest methodological quality
(based on method of randomization, allocation concealment, com-
pleteness of follow-up, and blinding of final assessment), or infor-
mation about the amount of mobilisation.
Intervention features: sensitivity analyses restricted to trials with
an earlier time-to-first mobilisation (mean time-to-first mobilisa-
tion of less than 24 hours) showed a similar primary outcome to
the main analysis (OR 1.10, 95% CI 0.93 to 1.29; P = 0.27; I2 = 78%),
and an odds of death of 1.35 (95% CI 0.99 to 1.83; P = 0.06; I2 =
25%; AVERT II 2008; AVERT III 2015; Chippala 2015a; Chippala 2015b;
Sundseth 2012). Analyses restricted to the trials that clearly record-
ed a more prolonged out-of-bed activity, showed a similar prima-
ry outcome (OR 1.14, 95% CI 0.96 to 1.35; P = 0.13; I2 = 28%), and
odds of death (OR 1.27, 95% CI 0.93 to 1.73; P = 0.13; I2 = 0%) to the
main analysis (AVERT II 2008; AVERT III 2015; Langhorne 2010; Po-
letto 2015).
Network meta-analysis (NMA)
This review included trials that aimed to compare the effect of
reducing time-to-first mobilisation (TTFM), with or without an in-
crease in the amount or frequency of mobilisation activities, with
usual care (where TTFM started later). However, it was clear that
within this definition, the included trials would comprise a range
of different comparisons. Therefore, we conducted an explorato-
ry, post-hoc, network meta-analysis (NMA) to explore, where possi-
ble, the impact of treatment characteristics (TTFM and amount of
mobilisation activity). NMA analysis by the amount of mobilisation
activity was not possible, because this information was not consis-
tently reported (Table 1). However, we could categorise informa-
tion on TTFM into five major TTFM groups, with limited overlap.
Table 2 shows the categories of TTFM, with early mobilisation TTFM
in the columns, and usual care TTFM in the rows. The lower le& sec-
tion indicates the trials (participants) contributing to each direct
comparison of TTFM. Figure 4 shows the same comparisons in the
form of a network plot.
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Figure 4.   Network plot of all trials. Each point shows the time-to-first mobilisation (TTFM) classifications. The lines
show the number of trials directly comparing each TTFM category.
 
We believe that the transitivity (or similarity) assumption was met,
as all the included trials recruited people with acute stroke, within
48 hours of symptom onset, within a stroke unit (or similar) setting.
The IQR distribution for average age (65 to 73 years), gender (45%
to 57% male), and stroke severity (44% to 68% moderate or severe)
were broadly comparable (Table 1).
We evaluated the consistency assumption statistically, by compar-
ing the difference between the direct and the indirect estimate for
each loop of evidence. We examined for any inconsistency (i.e. im-
portant differences in numerical results between direct, indirect,
and network results), and we presented OR estimates for each of
the three comparisons.
We showed the inconsistency tables for the NMA for the analyses
of poor outcome (Table 3), and death (Table 4). These tables show
the results of direct and indirect comparisons, plus the NMA results.
There were no statistically significant differences between any of
the direct and indirect comparisons, but the confidence intervals
were wide (Table 5).
The NMA used the 24-hour TTFM group as the comparator, as
this was clinically relevant and incorporated the largest single tri-
al (AVERT III 2015). Figure 5 shows the NMA result for the poor out-
come (death or dependency) at three months. The lowest odds of
poor outcome was at 24 hours, although confidence intervals were
very wide. A similar pattern was seen for the outcome of death at
three months (Figure 6), but again with very wide confidence inter-
vals (Table 5).
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Figure 5.   Network meta-analysis plot for poor outcome (death or dependency at 3 months). The treatment column
shows the time-to-first mobilisation (TTFM) categories. The results are the odds ratio (95% confidence interval) for
the odds of a poor outcome with TTFM of 24 hours as the reference (OR = 1.0).
 
 
Very early versus delayed mobilisation aer stroke (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
19
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Figure 6.   Network meta-analysis plot for death at 3 months. The treatment column shows the time-to-first
mobilisation (TTFM) categories. The results are the odds ratio (95% confidence interval) for the odds of death with
TTFM of 24 hours as the reference (OR = 1.0).
 
Finally, we carried out a Rank analysis, which orders treatments ac-
cording to their relative effectiveness; the first ranked treatment is
most likely to be the most effective treatment, compared with the
other treatments in the network. This analysis rated the 24-hour
TTFM group to be the one most likely to be associated with efficacy
(P = 0.81 for poor outcome), and safety (P = 0.76 for death by three
months), indicating that 24-hour TTFM was the optimal option, al-
though our confidence was limited by the substantial imprecision.
D I S C U S S I O N
This systematic review aimed to assess the benefits or harms of
very early mobilisation (VEM) compared with conventional prac-
tice (usual care). We conducted a comprehensive search of citation
and clinical trial registries, and contacted researchers in the field
to identify unpublished studies. We identified 13 eligible RCTs, nine
(2958 participants) of which we included: three from China are cur-
rently underway or not yet published, and one is in the planning
stage (AVERT-DOSE 2017).
Summary of main results
The included trials incorporated different approaches to VEM, but
all included an earlier onset of out-of-bed mobilisation, and sever-
al reported providing a higher intensity (minutes per day) of mo-
bilisation activity. The primary outcome (death or poor outcome)
was not significantly altered by the mobilisation strategy. Neither
were the other major binary outcomes: death, death or dependen-
cy, death or requiring institutional care, presence of complications,
or ability to walk. We assessed the evidence for these outcomes as
being of moderate quality. There was an indication that VEM may
result in a higher ADL score among survivors, and a slightly short-
er length of hospital stay. However, these conclusions were based
on less reliable data that may have non-normal distributions, and
are more prone to bias (low-quality evidence). Sensitivity analyses
raised the possibility that trials with an earlier onset of VEM may
have had a higher risk of death at the end of follow-up.
The review was dominated by one large, multicentred trial, involv-
ing 2104 participants from six countries (AVERT III 2015). The results
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of AVERT III 2015 suggested a hazard with VEM (adjusted odds ratio
(OR) for death or dependency at three months was 1.37, 95% con-
fidence interval (CI) 1.11 to 1.69; P = 0.004). Pre-specified dose-re-
sponse analyses suggested that better outcomes were associated
with more frequent, and less prolonged episodes of mobilisation
(AVERT III 2015).
Overall completeness and applicability of evidence
Clearly, there is considerable research interest in this field; we iden-
tified a number of recent trials. Despite this significant body of po-
tentially relevant research, very few studies met the inclusion crite-
ria. One of the major problems we identified during our search for
relevant research, was that the term 'early rehabilitation' was used
to define interventions spanning a wide time interval. For example,
some authors used the term 'early' to describe an intervention that
commenced within 48 hours post stroke (Xue 2004), while other au-
thors described interventions commencing within three months of
stroke as 'early' interventions (Li 2002). It is likely that what clin-
icians and researchers consider as early rehabilitation is strongly
dependent on when rehabilitation usually commences within their
healthcare system, and that this varies considerably between coun-
tries.
The most common reason we excluded trials from this review was
that the mobilisation interventions in the experimental group com-
menced more than 48 hours after stroke symptom onset. Also, a
few studies failed to detail the time from stroke onset, instead not-
ing time from admission (e.g. Asberg 1989; Gao 2001). Given that
it can take patients hours or even days to reach hospital following
a stroke, these studies failed to provide a precise time point from
stroke onset to commencing intervention, and consequently, we
could not include the trials. Other studies provided insufficient in-
formation about the timing of the intervention to allow confirma-
tion that the trial met the inclusion criteria. We attempted to con-
tact study authors, and we are awaiting responses. Poor definition
of the intervention content and dose was also a problem in this re-
view. It was not uncommon to find interventions only broadly de-
fined, with limited information about how much mobilisation was
delivered by whom, how often, and over what time frame (days or
weeks). Once again, we attempted to contact the study authors to
seek further information.
Despite the uncertainties within the research field, our included tri-
als, in particular AVERT III 2015, appeared to have included a rep-
resentative patient population of those who are receiving cared in
routine stroke unit settings. These trials generally took a pragmat-
ic approach, and recruited a reasonably representative population
in terms of age, sex, stroke type, and stroke severity. The data com-
pleteness for the key binary outcomes was generally good, but less
secure for the continuous outcomes.
We planned the analysis of treatment characteristics in the expec-
tation that within our broad comparison of early versus later onset
mobilisation, the included trials would comprise a range of treat-
ment comparisons. Therefore, we included an exploratory post-
hoc network meta-analysis (NMA) to explore the impact of treat-
ment characteristics (time-to-first mobilisation, and amount of mo-
bilisation activity). We were unable to conduct NMA analysis by
the amount of mobilisation activity because this information was
not consistently reported between trials. However, we could cat-
egorise information on time-to-first mobilisation (TTFM) into five
major TTFM groups with limited overlap. This analysis suggested
that for both death and poor outcome (death or dependency) at
three months, the optimal TTFM was about 24 hours. However, con-
siderable caution is required in interpreting this result. First, this
was an exploratory post-hoc analysis. Second, the TTFM categories
were not absolutely discrete groups; we imposed the classification
to fit the available trials. Third, the trials differed in type and quan-
tity of mobilisation activity as well as TTFM. As a result, the con-
fidence intervals were wide, and we graded the quality of the evi-
dence as low. Therefore, we could conclude that further trials were
warranted, but the limited information available at present did not
indicate that any TTFM was superior to 24 hours (IQR 22 to 29).
Quality of the evidence
The nine trials included in the review showed a low risk of selection
bias and were largely secure against detection bias (Figure 2). The
most challenging aspect was the blinding of staH and participants.
For some rehabilitation interventions, such as VEM, it may not be
possible to have a truly double-blinded study; however, several tri-
als attempted to mitigate such potential sources of bias (AVERT II
2008; AVERT III 2015; Langhorne 2010; Morreale 2016). First, par-
ticipants were informed that they could be randomized to one of
two styles of rehabilitation (AVERT II 2008), or treatment protocols
(AVERT III 2015; Langhorne 2010), but the details of these protocols
were not usually explained in detail. Second, the intervention was
not made available to personnel beyond the treating staH, and ef-
forts were made to avoid contamination (e.g. by providing treat-
ment behind curtains (AVERT II 2008; AVERT III 2015; Langhorne
2010; Morreale 2016)).
Potential biases in the review process
Several of the review authors (JB, PL, JC, AS) were trialists in at least
one of the included trials. However, we ensured that trial selection
decisions were allocated in a manner that avoiding trialists making
decisions about their own trials.
Our review identified a substantial number of trials from China that
addressed the topic of early rehabilitation following stroke. We un-
derstand that current usual practice in many places in China, is
to provide little or no organised rehabilitation to people following
stroke. Therefore, it was likely that these trials, many of which were
undertaken over the past 10 years, reflected an increased interest in
the provision of rehabilitation to people with stroke. Unfortunately,
none of Chinese trials we identified in this review met the inclusion
criteria, because they provided either a complete multidisciplinary
rehabilitation program or package, which may or may not have in-
cluded a mobilisation component, and compared this with no reha-
bilitation (e.g. Xue 2004; Liu 2010e), or did not provide details of the
time of commencement of mobilisation (e.g. Zhang 1998). In view
of this rapidly growing body of Chinese research and the difficulties
associated with acquisition and translation of Chinese research, it
would be beneficial to form partnerships with Chinese researchers
on the topic of early rehabilitation (Zhang 2014).
The analyses of continuous outcomes reported in this review were
all subject to potential bias, and we rated them as providing low-
quality evidence (Summary of findings for the main comparison).
Although the main measure of activities of daily living (the Barthel
ADL index) is a 20-point ordinal scale, its characteristics in people
with stroke approximate to that of a continuous scale, and analy-
sis using mean and standard deviation is usually justifiable (Song
2006). However, we downgraded the ADL data, because there was
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a high level of statistical heterogeneity, and a substantial rate of
missing data (for instance, participants who died were not includ-
ed). Analysis of length of stay was confounded by the variable de-
finitions of length of stay, and the likelihood that these data may
be non-normally distributed. For both outcomes, re-analysis of in-
dividual patient data would provide a more reliable estimate of ef-
fect.
The network meta-analysis was exploratory in nature and had a
number of uncertainties. Therefore, we judged the evidence for
these conclusions to be low quality (Table 5).
Agreements and disagreements with other studies or
reviews
This review update appeared to add substantive information to
this field. Recent reviews published in this area identified fewer
new RCTs, and concluded that the benefits of commencing physical
rehabilitation within 24 hours of stroke were unclear. Lynch 2014
identified three new RCTs, and Bernhardt 2015 identified four RCTs,
and concluded that the evidence was inconclusive. Whaley 2016 in-
cluded two trials, and concluded that evidence supported a rested
approach to care within the first 24 hours of hospitalisation. Final-
ly, a recent review with different inclusion criteria concluded that
there were no beneficial effects from VEM (Xu 2017).
A U T H O R S '   C O N C L U S I O N S
Implications for practice
The approach to very early mobilisation (VEM) described in the tri-
als we reviewed always featured an earlier onset of out-of-bed mo-
bilisation activities, and often reported providing a higher intensi-
ty (time per day) of mobilisation activity. Overall, there was no sig-
nificant impact of VEM on the main clinical outcomes (death, de-
pendency, institutional care, presence of complications, ability to
walk), although the largest single trial, AVERT III 2015, found a sig-
nificant increase in death or dependency. We based our sugges-
tions that VEM may result in a higher ADL score among survivors
and a slightly shorter length of hospital stay on less reliable data
that were more prone to bias.
We believe that the evidence supported a cautious approach to ac-
tive mobilisation within 24 hours of stroke onset because the single
largest trial (AVERT III 2015), and a sensitivity analysis of trials re-
cruiting within 24 hours, raised the possibility that VEM commenc-
ing within 24 hours may carry some increased hazard. In addition,
low-quality evidence from an exploratory network meta-analysis
indicated that mobilisation at around 24 hours may be associated
with the best outcome.
Implications for research
Larger, high-quality trials of VEM are needed to clarify the rela-
tive harms and benefits of different mobilisation strategies. In par-
ticular, these studies need to clearly define the optimal timing of
commencement, frequency, and duration of mobilisation interven-
tions. Timing should be provided from time of stroke symptom
onset, not admission. Researchers must ensure publications fulfil
CONSORT guidelines, with adequate description of the experimen-
tal and control interventions (Moher 2001).
We recommend that researchers and clinicians move to using a
common terminology, as outlined in recent recommendations to
improve the development and reporting of rehabilitation trials
(Bernhardt 2017). We have proposed the term 'very early' rehabili-
tation to indicate interventions commencing within two days, and
'early' as those commencing three to seven days following stroke
onset (Bernhardt 2007). In this time-critical field of research, it is
also important that researchers clearly define when interventions
commenced (hours), and that the time is estimated from the start of
stroke symptom onset. Interventions should be described in a stan-
dard manner, such as with the TIDieR framework (Hoffman 2014).
In the interim, an individual patient data meta-analysis of the exist-
ing trials may help explore some of the current uncertainties.
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Characteristics of included studies [ordered by study ID]
 
Methods RCT of very early and intensive mobilisation versus standard care
Computer-generated blocked randomization, stratified by stroke severity and clinical site, opaque en-
velopes
Blinded outcome assessment, participants blind to group
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Participants Stroke units in 2 large teaching hospitals in Melbourne, Australia
71 participants: 38 intervention, 33 control
Mean age: 74.7 years
53.5% male
9 (13%) haemorrhagic stroke
Mean NIHSS 10
30 (42%) had mild stroke (NIHSS 1 to 7)
24 (33%) moderate stroke (NIHSS 8 to 16)
17 (24%) severe stroke (NIHSS > 16)
Inclusion criteria: acute stroke patients admitted within 24 hours of symptom onset to a stroke unit,
able to react to verbal commands, systolic BP 120 to 220 mmHg, oxygen saturation > 92% (with or with-
out supplementation), heart rate 40 to 100, temperature < 38.5 C
Exclusion criteria: premorbid mRS > 2, deterioration within first hour of admission to stroke unit, direct
admission to intensive care, concurrent progressive neurological disorder, acute coronary syndrome,
severe heart failure, lower limb fracture, palliative care
Interventions What
Procedures: VEM plus standard care versus standard care alone. The VEM group commenced mobilisa-
tion (upright and out of bed at least twice a day) as soon as practical, aiming to have first mobilisation
within 24 hours of stroke onset
Who provided
Mobilisation was delivered by a nurse-physiotherapist team
How
Mobilisation was delivered face-to-face by a nurse-physiotherapist team
Where
In the stroke unit
When and how much
VEM began within 24 hours and continued daily for 14 days post stroke, or until discharge
Tailoring
Participants were monitored during mobilisation within the first 3 days. Mobilisation could be halted in
the event of significant physiological changes
Modifications
The intervention protocol was not changed during the trial. The type and amount of mobilisation was
the same for infarct and haemorrhage
How well
Planned: time-to-first mobilisation and number of minutes of mobilisation (engaged in upright activi-
ties) were recorded
Actual: the median time-to-first mobilisation after symptom onset was 18.1 hours (IQR 12.8 to 21.5) in
the VEM group and 30.8 hours (IQR 23.0 to 39.9) in the standard care group (P < 0.001). The total num-
ber of minutes (median, IQR) of mobilisation achieved in the VEM group was double that of standard
care (VEM 167, 62 to 305, standard care 69, 31 to 115; P = 0.003)
Outcomes Mortality
AVERT II 2008  (Continued)
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'Severe' adverse events
'Non-severe' adverse events
Deterioration in the first 7 days
Perceived exertion (Borg scale)
Total dose of mobilisation
Time from stroke onset to first mobilisation
mRS (disability or dependency)
Contamination (increase in mobility in a random sample of standard care participants)
Irritability, Depression, and Anxiety (IDA) scale
Assessment of Quality of Life scale
Notes Trial ran from 2004 to 2006
Follow-up period: primary outcome 3 months, final follow-up 12 months
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "We used computer-generated, blocked randomization procedures
with stratification by stroke severity and clinical site"
Allocation concealment
(selection bias)
Low risk Quote: "Opaque envelopes concealed the group allocation"
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Low risk Quote: "Patients were advised that they would be randomized to 1 of 2 styles
of rehabilitation, A or B. Trial therapists and nursing staH could not be blinded
to intervention group. To limit knowledge of VEM, interventions were conduct-
ed by dedicated trial staH out of sight of ward staH or behind closed curtains
wherever possible"
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Quote: "All outcomes were assessed by a blinded assessor located oH-site".
To assess whether protocols to blind the assessor to group were effective,
the blinded assessor was asked to select (forced choice) to which group they
thought the participant had been allocated. This procedure was introduced
in the third month of the study. A correct guess was made in 34/56 cases. This
was no better than chance (P = 0.25)
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Only 2 participants (2/71) lost to follow-up
Selective reporting (re-
porting bias)
Low risk Primary outcome largely complete
AVERT II 2008  (Continued)
 
 
Methods AVERT III was a prospective, parallel group, assessor-blind, randomized, multi-centre, international
clinical trial. Participants were randomized in a ratio of 1:1 to 2 groups: 1) very early and frequent mo-
bilisation out of bed (VEM); and 2) usual care (UC)
Participants International, multicentre trial carried out in 56 stroke units in Australia, New Zealand, Singapore,
Malaysia, and the UK (England, Scotland, Northern Ireland, and Wales) and recruiting acute stroke pa-
tients admitted to hospital within 24 hours of symptom onset
2104 participants recruited: 1054 intervention, 1050 control
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Mean age: 72.5 years
818/2104 (39%) men
258/2104 (12%) haemorrhagic
Median NIHSS 7
1170 (55%) had mild stroke (NIHSS 1 to 7)
642 (31%) moderate stroke (NIHSS 8 to 16)
291 (14%) severe stroke (NIHSS >16)
Thrombolysis treatment in 24%
Inclusion criteria:
• first or recurrent, ischaemic or haemorrhagic stroke (but not transient ischaemic attack);• recruited within 24 hours of onset of stroke symptoms;• aged 18 years or more;• admitted to a stroke care unit• must at least react to verbal commands
Exclusion criteria:
• pre-stroke disability (mRS score of 3 to 5);• deterioration in condition in the first hour of admission resulting in admission to ICU;• decision for palliative treatment (e.g. those with devastating stroke) or immediate surgery or concur-
rent diagnosis of rapidly deteriorating comorbidity;• unstable other medical condition that is judged by the investigator to impose a hazard to the patient
by involvement in the trial;• lower limb fracture at the time of stroke preventing the implementation of the mobilisation protocol;• concurrent recruitment to another intervention trial;• physiological instability (systolic blood pressure less than 110, or greater than 220 mmHg, oxygen
saturation < 92% with oxygen supplementation, resting heart rate < 40 or > 110 beats per minute,
temperature > 38.5°C)
Treatment with rtPA was not an exclusion criteria if the attending physician permitted mobilisation to
commence within 24 hours of stroke onset
Interventions What
Materials: participant could receive usual care alone (UC) or very early and frequent mobilisation (VEM)
in addition to usual care. The intervention followed a protocol (AVERT Intervention Protocol version 3,
dated 25 April 2008) detailing a strict 'first time out of bed protocol'. The intervention protocol was only
distributed to trial intervention staH and ethics committees in order to help maintain blinding and pro-
tect against treatment contamination in the trial. The intervention was task specific with a focus on re-
covery of standing and walking. The protocol allowed 4 levels of activity ranging from 4 transitions/day
in severe patients (baseline NIHSS > 16) to 16 transitions/day in mild patients (baseline NIHSS 0 to 7)
Procedures: VEM participants commenced out-of-bed activity within 24 hours of stroke onset, to con-
tinue out of bed activity at a frequency and intensity guided by a detailed intervention protocol (avail-
able from the investigators)
Who provided
VEM was provided by physiotherapy and nursing staH trained in study procedures
How
VEM was provided face-to-face by physiotherapy and nursing staH
Where
AVERT III 2015  (Continued)
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VEM was provided in the stroke unit
When and how much
VEM began within 24 hours and lasted for 14 days or until the participant was discharged from stroke
unit care. The VEM intervention included 3 key elements: 1) begin within 24 hours of stroke onset; 2) fo-
cus on sitting, standing, and walking (i.e. out-of-bed) activity; and 3) result in at least 3 out-of-bed ses-
sions in additional to usual care. Participants assigned to VEM were assisted to continue out-of-bed ac-
tivity at a dose guided by a detailed intervention protocol (see above)
Tailoring
The intervention followed a protocol that outlined the safety ranges for blood pressure, heart rate, oxy-
gen saturation and temperature prior to first mobilisation. It advised that mobilisations should only
proceed if the patient’s blood pressure does not fall by > 30 mmHg on sitting up on the edge of the bed,
or on getting out of bed
Modifications
The intervention protocol was not changed during the trial
How well
Planned: monitoring included time-to-first mobilisation plus number and duration of out-of-bed mobil-
isation sessions
Actual: the VEM group was noted to have a significantly (P < 0.01) reduced time-to-first mobilisation
from stroke onset (median 18.5 hours vs 22.4 hours) and increased median number of out-of-bed train-
ing sessions per day (6.5 vs 3) and increased median amount of out-of-bed training time per day (31 vs
10 minutes)
Outcomes mRS at 3 months, evaluation of adverse effects, health-related quality of life, cost effectiveness and
cost utility, long-term efficacy, activity limitation, dose response, patient severity, and staH injury
Notes Trial ran from 2008 to 2014
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk A remote, web-based, computer-generated randomization procedure was
used. Randomisation was balanced by site and stratified by stroke severity,
based upon the patient’s baseline NIHSS score
Allocation concealment
(selection bias)
Low risk All online submissions were secured by use of password and data encryption
procedures. Once participant recruitment data were submitted by the site staH
to the trial website (AVERT Online), the randomization allocation was immedi-
ately provided to the investigator
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Low risk Participants were aware that they could be randomized to 1 of 2 mobilisation
protocols but were not provided with details. The intervention protocol was
only distributed to trial intervention staH and ethics committees in order to
help maintain blinding and protect against treatment contamination in the tri-
al
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk The 3- and 12-month assessments were conducted in person or by telephone
by an assessor who was remote from the location of the acute treatment of the
participant and blind to treatment allocation
Incomplete outcome data
(attrition bias) 
Low risk The total number of participants missing for the primary outcome was only
21/2104 (1%)
AVERT III 2015  (Continued)
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All outcomes
Selective reporting (re-
porting bias)
Low risk Primary outcome largely complete
AVERT III 2015  (Continued)
 
 
Methods Single-blinded RCT with a blinded assessment at the end of follow-up
Participants Acute stroke patients admitted to the stroke unit within 24 hours of symptom onset
Both sexes
Able to react to verbal commands
Medical condition stable and physiologically stable (systolic BP 120 to 180 mmHg, oxygen saturation >
92%, heart rate 40 to 100 beats per minute, temperature < 38.5°C)
86 participants: 43 intervention, 43 control
Mean age: 60 years
42/80 (52%) men
16/80 (20%) haemorrhagic
27 (34%) had mild stroke (NIHSS 0 to 7)
42 (52%) moderate stroke (NIHSS 8 to 16)
11 (14%) severe stroke (NIHSS > 16)
Interventions What
Materials: the trialists "adopted the AVERT Protocol. The intervention group received the following ac-
tivities: sitting supported in bed, sitting unsupported out of bed, transfer with assistance, roll and sit
up, sitting without support, transfer feet on the floor, standing activities, walk-early gait, and advanced
gait activities"
Who provided
Not stated
How
Not stated
Where
Provided in the stroke unit
When and how much
Intervention: "The mobilisation was started (upright and out-of-bed activities) as soon as practical after
the recruitment, aiming to have first mobilisation within 24 hours of the onset of the symptoms"
Standard care: "Patients in the standard care group received routine stroke unit care, including the
passive and active (if possible) mobilisation, correct positioning in bed, mobilisation in bed, sitting bal-
ance activities, facilitation of limb and trunk control activities, education of patient and caregiver. Both
groups received standard care treatment, for 45 minutes a day, for seven days or until discharge"
Tailoring
Chippala 2015a 
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"The time spent on early and frequent out-of-bed activities was determined by the patient’s tolerance
(5 to 30 minutes), and they received mobilisation for a minimum of two times per day for seven days or
until the discharge, whichever was sooner"
Modifications
Not stated
How well
Planned: "The mobilisation was started (upright and out-of-bed activities) as soon as practical after the
recruitment, which aimed to have first mobilisation within 24 hours of the onset of the symptoms. The
time spent on early and frequently out-of-bed activities was determined by the patient’s tolerance (5
to 30 minutes), and they received mobilisation a minimum of two times per day for seven days, or until
the discharge whichever was sooner"
Actual: "time to first mobilization after the symptom onset was a median 18 hours (IQR 16.62 to 19.75)
in the intervention group and a median 30.5 hours (IQR 29.0 to 35) in the standard care group (P <
0.001)"
Outcomes Primary outcome: Barthel index at the end of 3 months following the onset of stroke
Length of hospital stay
Notes Study took place March 2012 to September 2014
Reported to be a different study and patient group from Chippala 2015b
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "randomly allocated equally to either the Intervention group (very ear-
ly mobilization, out of bed within 24 hours of stroke onset) or the standard
care group, by the computer-generated, randomization procedures"
Allocation concealment
(selection bias)
Low risk Quote: "randomly allocated equally to either the Intervention group (very ear-
ly mobilization out of bed within 24 hours of stroke onset) or the standard care
group by the computer-generated, randomization procedures, using a con-
cealed opaque envelop method. This randomization list was held by a univer-
sity researcher who was not related to any part of the study"
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk Quote: "Single blind, randomized controlled trial"
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Quote: "The outcome measurements at three-month follow-up were taken di-
rectly by the blinded assessor when the patients visited the hospital for a rou-
tine medical check-up"
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 6/86 (7%) missing at 3 months
Selective reporting (re-
porting bias)
Unclear risk Primary outcome largely complete
Chippala 2015a  (Continued)
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Methods Single blinded, parallel grouped, RCT with a blinded assessment at the end of follow-up
Participants Stroke patients admitted to the stroke unit within 24 hours of symptom onset and physician permission
to mobilise within 24 hours of stroke
Both sexes
Able to react to verbal commands
Medical condition stable and physiologically stable (systolic BP 120 to 180 mmHg, oxygen saturation >
92%, heart rate 40 to 100 beats per minute, temperature < 38.5°C)
Mean age: 63.3 years
54 participants: 27 intervention, 27 control
28/49 (57%) men
11/49 (22%) haemorrhagic
27/48 (56%) had mild stroke (NIHSS 0 to 7)
21/48 (44%) moderate stroke (NIHSS 8 to 16)
Interventions Same as Chippala 2015a
Both the groups received standard care treatment including routine stroke unit care, for 45 minutes a
day, for seven days, or until discharge
The intervention group received VEM mobilisation activities, initiated within 24 hours of the stroke on-
set, in addition to the standard care. They performed early and frequent out-of-bed activities including
sitting, standing, walking. The duration of mobilisation was determined by the participant's tolerance
(5 to 30 minutes) with a frequency of a minimum of 2 times per day for 7 days or until the discharge,
whichever was sooner
Outcomes The mRS at 3 months. A good outcome was defined as mRS of 0 to 2
Barthel Index at 3 months
Adverse events during first 3 months
Length of hospital stay (days)
Notes Study took place from September 2014 to June 2015
Reported to be a different study and patient group from Chippala 2015a
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "single blinded, parallel grouped, randomized controlled trial with a
blinded assessment at the end of follow-up"
Allocation concealment
(selection bias)
Low risk Quote: "randomization procedures using a concealed opaque envelop
method"
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk Quote: "single blinded, parallel grouped, randomized controlled trial with a
blinded assessment at the end of follow-up"
Blinding of outcome as-
sessment (detection bias) 
Low risk Quote: "single blinded, parallel grouped, randomized controlled trial with a
blinded assessment at the end of follow-up"
Chippala 2015b 
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All outcomes
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 5/54 (9%) missing at follow-up
Selective reporting (re-
porting bias)
Unclear risk Primary outcome largely complete
Chippala 2015b  (Continued)
 
 
Methods A pilot randomized trial (using a 2 x 2 factorial design) to compare conventional stroke unit procedures
with more progressive (nurse-led) protocols of early mobilisation (EM), automated physiological moni-
toring, or both
As there was no statistical interaction between the 2 protocols, the EM arms were compared directly
with the normal mobilisation arms
Participants 1 stroke unit in Glasgow, Scotland
Recruited 32 acute stroke patients admitted to hospital within 24 hours (and recruited within 36 hours
of symptom onset) with no premorbid severe disability
Of the 16 EM patients, 8 were allocated to the EM protocol alone and 8 to the EM plus automated moni-
toring protocols
Of the 16 controls, 8 were allocated to normal mobilisation alone and 8 to normal mobilisation plus the
automated monitoring protocol
Mean age: 67.5 years
16/32 (50%) men
1/32 (3%) haemorrhagic
Mean NIHSS 5
23 (72%) had mild stroke (NIHSS 1 to 7)
7 (22%) moderate stroke (NIHSS 8 to 16)
2 (6%) severe stroke (NIHSS > 16)
Interventions What
Materials: protocols for early mobilisation (VEM) or intensive physiological monitoring, or both, or stan-
dard care alone (control). VEM was planned to be similar to AVERT protocol but did not have access to
the same written protocol.
Procedures: the VEM protocol aimed to get participants up to sit, stand, and walk within 24 hours of the
stroke and continue this at least 4 times per day
Controls: the stroke unit had a philosophy of getting patients up to sit, stand, and walk early but did not
have staH specifically allocated to this role. Mobilisation was normally provided by physiotherapists
and nurses (30 to 60 minutes per day). Normal monitoring involved intermittent (4-hourly) checking of
pulse, temperature, oxygen saturation, and blood pressure
Who provided
The research nurse had a role ensuring the VEM protocol was implemented in conjunction with physio-
therapy and nursing staH
How
Langhorne 2010 
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The research nurse facilitated the VEM protocol that was largely delivered face-to-face by physiothera-
py and nursing staH
Where
Provided in the stroke unit
When and how much
For 1 week after recruitment or until discharge
Tailoring
EM could be adapted according to the abilities of the participant
Modifications
Mobilisation could be halted if monitoring of pulse, temperature, oxygen saturation, or blood pressure
suggested abnormal changes
How well
Planned: the EM protocol aimed to get participants up to sit, stand, and walk within 24 hours of the
stroke and continue this at least 4 times per day. This was monitored as: 1) time-to-first mobilisation
(attempt to get the participant out of bed, to sit, stand, or walk); 2) best level of mobilisation activity
achieved (lying, sitting, standing, walking); and 3) participant activity (using automated activity moni-
tor recordings)
Actual: median time from stroke to first mobilisation in the VEM group was 27.3 hours (IQR 26.0 to 29.0)
vs 32.0 hours (IQR 22.5 to 47.3) in controls (P = 0.31), however a significantly greater number of EM par-
ticipants (P = 0.03) were mobilised within 1 hour of randomization. A significantly great number of EM
participants (P = 0.02) achieved standing or walking when mobilisation was recorded using activity
monitors
Outcomes mRS at 3 months, adverse events, patient activity, neurological deterioration, Barthel Index at 1 week
and 3 months, walking speed (1 week and discharge), patient satisfaction, resource allocation
Notes Recruitment took place in February 2007 to January 2008
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk The randomization sequence was to 1 of 4 nurse-led treatment protocols (2 of
which delivered EM). The sequence was computer-generated in blocks of 4
Allocation concealment
(selection bias)
Low risk Quote: "patients were then randomly allocated by telephoning a secretary in
an independent office who logged the patient and opened the next in a series
of sequentially numbered opaque sealed envelopes"
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Participants were aware that they were being randomized to different care
protocols. No specific measures were in place to segregate participants but
recruitment did not result in participants receiving different protocols in the
same ward space
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Key outcome observations were blinded to treatment allocation by using an
independent assessor at day 5 and at 3 months
Incomplete outcome data
(attrition bias) 
Low risk No losses after randomization
Langhorne 2010  (Continued)
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All outcomes
Selective reporting (re-
porting bias)
Low risk Primary outcome complete
Langhorne 2010  (Continued)
 
 
Methods Multicenter, factorial, single blind RCT
Participants First ischaemic stroke (middle cerebral artery) 6 to 24 hours from onset
Exclusion criteria included: mild stroke (NIHSS < 2), MMSE < 26, neurological or cardiovascular instabili-
ty, significant comorbidity
340 participants: 220 intervention, 120 control
Mean age: 64 years
246/340 (72%) men
0/340 (0%) haemorrhagic
37 (11%) had mild stroke (NIHSS 3 to 6)
260 (76%) moderate stroke (NIHSS 7 to 14)
43 (13%) severe stroke (NIHSS > 14)
Interventions What
A factorial design was used to compare early proprioceptive neuromuscular facilitation (PNF) or cog-
nitive therapeutic exercise (CTE) commenced within 24 hours of admission, with delayed PNF and CTE
groups, where treatment started 4 days later
Materials: all physiotherapists were specifically trained for treatment protocols.
Procedures: early rehabilitation: daily out-of-bed activity with either PNF or CTE commenced within 24
hours
Usual care: routine hospital care for first 4 days, followed by either PNF or CTE
Who provided
Physiotherapists
How
Physiotherapists were specifically trained for treatment protocols and were not aware of the clinical
features and study objective
Where
Neurology department of 2 stroke centres in Rome
When and how much
Early rehabilitation: daily out-of-bed activity (with either PNF or CTE). Dose set as 1 hour/day for first 4
days; followed by 2.25 hours/day, daily for 14 weeks; followed by 1.5 hours/day, 5 days/week until final
medical follow-up (mean of 38 weeks)
Usual care: routine hospital care for first 4 days, followed by either PNF or CTE. Dose based on standard
hospital care for first 4 days, and (from day 5) as per early rehabilitation groups
Tailoring
Morreale 2016 
Very early versus delayed mobilisation aer stroke (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
42
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Not stated
Modifications
Not stated
How well
Planned: a physical therapists' co-ordinator monitored the adherence to and homogeneity of treat-
ment protocols in all settings
Actual: not reported
Outcomes Primary outcome measures were disability (mRS and Barthel Index) at 3 and 12 months
Secondary outcomes:
• safety - immobility-related adverse events at 3 and 12 months.• Six Minute Walking Test• Motricity index• MMSE• Beck Depression Inventory
Notes Trial ran between January 2008 and January 2013
Loss to follow-up was not divided by group
3 months: 13 dead, 25 'lack of compliance'
12 months: 16 dead, 27 'lack of compliance', 4 recurrent stroke
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated randomization sequence in blocks of 4 to 1. A factorial
design was used to compare early proprioceptive neuromuscular facilitation
(PNF) or cognitive therapeutic exercise (CTE) commenced within 24 hours of
admission, with delayed PNF and CTE groups, where treatment started 4 days
later
Randomisation was stratified by age, sex, risk factors, stroke aetiology, side,
NIHSS score
Allocation concealment
(selection bias)
Unclear risk Quote: "..physical therapists' coordinator randomly assigned all patients..."
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk Quote: "All physiotherapists were specifically trained for treatment protocols
and were unaware of clinical features....and study objective"
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk All scales at 3 and 12 months were administered by "two different neurologists
who were blinded for treatment".
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk 25/340 (7%) of participants were lost to follow-up at 3 months and 27/340 (8%)
at 12 months due to 'lack of compliance'
Morreale 2016  (Continued)
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Selective reporting (re-
porting bias)
Unclear risk Primary outcome largely complete
Morreale 2016  (Continued)
 
 
Methods Cognitive therapeutic exercise (CTE) subgroup of Morreale 2016
Participants  
Interventions  
Outcomes  
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk See Morreale 2016
Allocation concealment
(selection bias)
Unclear risk See Morreale 2016
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk See Morreale 2016
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk See Morreale 2016
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk See Morreale 2016
Selective reporting (re-
porting bias)
Unclear risk See Morreale 2016
Morreale 2016 CTE 
 
 
Methods Neuromuscular facilitation (PNF) subgroup of Morreale 2016
Participants  
Interventions  
Outcomes  
Notes  
Morreale 2016 PNF 
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk See Morreale 2016
Allocation concealment
(selection bias)
Unclear risk See Morreale 2016
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk See Morreale 2016
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk See Morreale 2016
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk See Morreale 2016
Selective reporting (re-
porting bias)
Unclear risk See Morreale 2016
Morreale 2016 PNF  (Continued)
 
 
Methods Quote: "randomized, controlled, single-blind clinical trial compared early mobilization (within 48 h of
symptom onset) with routine physical therapy"
Participants Quote: "adult patients with CT- or MRI-confirmed ischemic stroke within 48 h of symptom onset who
were admitted on weekdays from March to November 2012 to the acute vascular unit or general emer-
gency unit of a large urban emergency department"
39 participants: 19 intervention, 20 control
Mean age: 65 years
13/37 (35%) men
0/37 (0%) haemorrhagic
Mean NIHSS score of 10.5
11 (30%) had mild stroke (NIHSS 0 to 5)
12 (32%) moderate stroke (NIHSS 6 to 11)
14 (38%) severe stroke (NIHSS > 11)
Interventions What
Materials: unclear for staH but "patients and their families received a manual developed for the study,
with guidance on positioning in bed and posture shifting to use at home after discharge"
Procedures: these "focused on getting out of bed, sitting in a chair, or standing (whenever and as soon
as possible), and conducting functional training and motor relearning, pursuant to the Bobath concept.
Exercises were performed bilaterally with at least 5 repetitions for each joint and each exercise, with
emphasis on deficits on the impaired side. In addition, patients and their families received a manual
Poletto 2015 
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developed for the study, with guidance on positioning in bed and posture shifting to use at home after
discharge. Intervention patients were mobilized 5 times a week, once a day, for approximately 30 min
per session, in addition to sitting out of bed for at least 30 min whenever possible"
Controls: they received "conventional physical therapy performed when requested by the staH. Ther-
apy varied according to the patients’ needs and the availability of physical therapists but general-
ly included global motor exercises and respiratory therapy (ordinarily in bed). The duration of stan-
dard-care therapy sessions was approximately 15 min"
Who provided
Quote: "The program was carried out by trained physical therapists"
How
Quote: "The program was carried out by trained physical therapists"
Where
The acute vascular unit or general emergency unit of a large urban hospital in Brazil.
When and how much
Quote: "Exercises were performed bilaterally with at least 5 repetitions for each joint and each exercise,
and emphasis on deficits on the impaired side. Intervention patients were mobilized 5 times a week,
once a day, for approximately 30 min per session, in addition to sitting out of bed for at least 30 min
whenever possible". "Sessions were held until hospital discharge or the 14th treatment day, whichever
occurred first, regardless of where the patient was located"
Tailoring
Not stated
Modifications
Not stated
How well
Planned: "The session duration (in minutes) and number of sessions were recorded. Sessions were held
until hospital discharge or the 14th treatment day, whichever occurred first, regardless of where the
patient was located"
Actual: "Intervention patients received mobilization earlier and more frequently than controls (table 2).
The median time from stroke to first mobilization was 43 h (vs. 72 h in the CG), and the total duration of
mobilization during the hospitalization period was 135 min (IQR 85 to 213; vs. 0 min in the CG (IQR 0 to
50)). Only 2 patients did not initiate early mobilization (within 48 h) in the IG. Moreover, only 5 patients
in the CG (26%) received physical therapy during hospitalization, with an average duration of 15 min
per session. After hospital discharge, 57% of the patients in the IG and 37% in the CG underwent physi-
cal therapy sessions (P = 0.28). IG patients had more out-of-bed activities compared with controls (4.3
vs 0.3), initiating activities while still in the ED. Only the 5 patients who received physical therapy in the
CG le& their beds; all other controls remained bedbound during hospitalization"
Outcomes The trialists "sought only to evaluate the feasibility and safety of the intervention. The primary out-
come measures were functional capacity (mRS score 0 to 2) and mortality at 3 months.
Feasibility endpoints were (a) time-to-first mobilisation, and (b) total duration of motor physical thera-
py.
Safety endpoints were: (a) complications during early mobilisation (first 48 h), i.e. symptomatic hy-
potension (syncope or presyncope) or neurological deterioration (defined as any worsening in NIHSS
score); (b) falls during hospitalisation and within 3 months of stroke; (c) complications related to immo-
bility (pneumonia, pulmonary embolism, and deep vein thrombosis) at 3 months, and (d) death within
3 months.
Poletto 2015  (Continued)
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Secondary outcomes were measured at 3 months (mRS score 0 to 1, mRS score 0 to 2, mean NIHSS
score, and mBI ≥ 85)".
Notes ClinicalTrials.gov NCT01694992
Reported as a pilot RCT that recruited from March to November 2012. Planned recruitment was for 174
participants (82 per group) but was limited by slow recruitment
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "Randomization was performed online (randomization.com) by a study
investigator, using a randomization plan stratified by blocks of varying sizes
(blocks of 2, 4, or 6)"
Allocation concealment
(selection bias)
Low risk Quote: "randomly allocated to an intervention group (IG) or a control group
(CG), with the allocation records stored in opaque, sealed, and sequentially
numbered envelopes"
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk Quote: "Patients were informed that they would begin physical therapy on the
first day of assessment (IG) or follow the hospital routine (CG)"
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Quote: "Baseline and postintervention measures were performed by a study
investigator who remained blinded to group allocation. To ensure blinding of
any monitoring neurologists, no notes of group allocation were made in the
hospital’s electronic medical record".
Incomplete outcome data
(attrition bias) 
All outcomes
High risk 6/39 (15%) missing at 3 month follow-up
Selective reporting (re-
porting bias)
Low risk Primary outcome largely complete
Poletto 2015  (Continued)
 
 
Methods Prospective multicenter RCT testing 2 sitting procedures at the acute phase of ischaemic stroke
Participants Acute ischaemic stroke patients recruited from 11 centres in the North West region of France
Participants were: over 18 years age, had neurological deficits, haemorrhage excluded on imaging, en-
rolled in a healthcare plan (French social security)
Exclusions included; very mild (NIHSS < 3) or very severe stroke (NIHSS > 22), reduced consciousness
Glasgow Coma Score < 13), fluctuating neurological signs (history of worsening linked to an upright po-
sitioning), known symptomatic intra-cranial stenosis > 50%, vomiting or difficulty in breathing, con-
traindication for sitting, e.g. deep vein thrombosis or lower limb fracture, prior dependency Rankin
score 3 to 6, anticipated difficulty in follow-up
167 participants: 82 intervention, 85 control
Mean age: 70 years
89/138 (64%) men
0/138 (0%) haemorrhagic
SEVEL 2016 
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Mean NIHSS 7.5
76 (56%) had mild stroke (Rankin score 0 to 3)
45 (34%) moderate stroke (Rankin score 4)
13 (10%) severe stroke (Rankin score 5)
Interventions What
This study aimed to test 2 different protocols for sitting in acute ischaemic stroke patients.
Early protocol: participants seated out of bed at the earliest time possible, ideally the day of stroke on-
set (day 0) and no later than the calendar day after stroke onset
Progressive protocol: the participant would be positioned in bed at 30°, 45° the day after (day 1), and
60° at day 2, and sitting out of bed at day 3 (which corresponds to the first sitting in this group). Those
angles reflect the position of the upper body relative to the bed (and floor)
Who provided
The physiotherapist or the nurses were in charge of collecting the data (e.g. blood pressure, tolerance)
related to the protocol
How
For both protocols, minimal duration of the first sitting was 15 minutes. The procedure could be con-
tinued, depending on participant fatigue and tolerance (60 minutes maximum). The physiotherapist or
the nurses were in charge of collecting the data (blood pressure, tolerance. . .) related to it. Sitting pos-
ture (legs dangling or feet positioned on a foot rest), was done as usual, in keeping with each unit’s pro-
tocol. The use of a li&er, when necessary, was allowed
Where
Stroke centres of 11 hospitals in North West France
When and how much
For both protocols, minimal duration of the first sitting was 15 minutes. The procedure could be contin-
ued, depending on patient fatigue and tolerance (60 minutes maximum). Sitting was repeated on a dai-
ly basis according to initial tolerance of the procedure, as approved by the physician in charge
Tailoring
Close monitoring of blood pressure and heart rate was performed: before the sitting procedure, imme-
diately after, and 5 minutes after. While sitting, participants showing any sign of low tolerance, defined
by neurological worsening (of current or new neurological deficits), vagal reaction (bradycardia or nau-
sea), a greater than 40 mmHg increase of blood pressure topping 180/100 mmHg, or a symptomatic de-
crease in blood pressure, would be put back in bed. Sitting was repeated on a daily basis according to
initial tolerance of the procedure, as approved by the physician in charge
Modifications
While sitting, participants showing any sign of low tolerance, defined by neurological worsening (of
current or new neurological deficits), vagal reaction (bradycardia or nausea), a greater than 40 mmHg
increase of blood pressure topping 180/100 mmHg, or a symptomatic decrease in blood pressure,
would be put back in bed
How well
Planned: the early protocol intended that participants would be seated, out of bed, at the earliest time
possible, no later than the calendar day after stroke onset. In the progressive protocol, the participant
would be positioned in bed at 30°, 45° the day after (day 1), and 60° at day 2, and sitting out of bed at
day 3 (which corresponds to the first sitting in this group)
SEVEL 2016  (Continued)
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Actual: time from stroke to the first sitting time was 1.1 ± 0.2 days in the early sitting group versus 3 ±
0.2 days in the progressive group
First sitting lasted significantly longer in the progressive group compared to the early group: 83.7 ± 94.7
minutes versus 56.6 ± 41.7 minutes respectively (P < 0.05). Tolerance of the sitting procedure was the
same in the early and progressive sitting groups, with a prevalence of side effects of 14.5% and 13.7%,
respectively. Sitting was continued daily for both groups during hospitalisation in 96% of cases.
NB: a small amount of out-of-bed activity was incorporated in transferring between bed and chair,
which started 2 days earlier in the intervention group than the standard care group
Physiotherapy and deep vein thrombosis prevention by low molecular weight heparin were performed
as usual in each unit
Outcomes The primary outcome measure was the proportion of mRS 0 to 2 at 3 months visit after stroke onset
Secondary outcomes were assessed at 7 days (or the day of discharge, if before 7 days), and the 3-
month follow-up and included:
• NIHSS score, Rankin score, Barthel score;• data about the tolerance of the sitting positioning (including prevalence of side effects that forced
termination of the procedure);• length of hospitalisation;• complications that occurred during hospital stay were reviewed at 3 months using a multiple-choice
list, and based on both participant interview and medical records;• duration of sitting out of bed was calculated from the recorded time at which the participant was
positioned seated out of bed to the time at which the participant would be put back in bed
Notes SEVEL (Stroke and Early VErticaL positioning) study
clinicaltrials.org registration number NCT01573299
The enrolment period covered November 2011 to April 2014. The study ended prematurely (after 167 of
a target of 400) as it became unviable, due to the slow recruitment rate
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "The random sequence was generated by our statistician (CV) using the
SAS software"
Allocation concealment
(selection bias)
Low risk Randomisation between the early and progressive sitting groups was per-
formed via "numbered sealed envelopes that the investigator would draw
from, in consecutive fashion (with blocks of 4 in 1:1 ratio, stratified by center)
each time a patient was enrolled in the study"
Quote: "Data were reported online using a server dedicated to the study"
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Probably not blinded
Blinding of outcome as-
sessment (detection bias) 
All outcomes
High risk Quote: "Evaluations were made during the intermediate time point at 7 days
(or the day of discharge, if before 7 days) and at 3 months after stroke, by a
neurologist from the same stroke unit, aware of the study and unblinded to the
patient group assignment"
Incomplete outcome data
(attrition bias) 
High risk Substantial drop out (29/167; 17%) after randomization
SEVEL 2016  (Continued)
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All outcomes Participants with major deviation to the protocol or serious adverse event that
were enrolled but could not continue the study were assigned a Rankin score
in the category 3 to 6
Selective reporting (re-
porting bias)
Unclear risk Primary outcome largely complete
SEVEL 2016  (Continued)
 
 
Methods Prospective RCT with blinded assessment at follow-up
Participants 1 stroke unit in Akershus, Norway
Acute stroke patients (infarct or haemorrhage), defined according to the WHO criteria, admitted to the
stroke unit within 24 hours of stroke
Exclusion criteria included; age < 18 years, prior dependency (mRS score 1 to 5), secondary haemor-
rhage, acute coronary disease, treated with thrombolysis or thrombectomy
65 participants recruited (12 lost to follow-up): 32 intervention (7 lost after randomization), 33 control
(5 lost after randomization)
Mean age: 77 years
25/56 (45%) men
5/56 (18%) haemorrhagic
Mean NIHSS 8
37 (66%) had mild stroke (NIHSS 1 to 7)
11 (20%) moderate stroke (NIHSS 8 to 16)
8 (14%) severe stroke (NIHSS > 16)
Significantly lower prevalence of diabetes in the intervention group: 2/27 (7%) vs 8/29 (28%); P = 0.05
Interventions What
Materials: both groups received standard stroke unit care. No detailed mobilisation protocol was used.
Procedures: VEM participants were mobilised out of bed as soon as possible after randomization and at
least 24 hours from admission to hospital. Mobilisation, meaning all out-of-bed activities, was carried
out several times per day. Control participants started mobilisation 24 to 48 hours from admission
Who provided
VEM was performed by physiotherapists, nursing staH, and occupational therapists
How
VEM participants were mobilised out of bed as soon as possible after randomization and at least 24
hours from admission to hospital by physiotherapy, nursing, and occupational therapy staH
Where
In the stroke unit
When and how much
Until discharge from the stroke unit
Tailoring
Sundseth 2012 
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All mobilisation was adjusted to the participant's needs and abilities. A neurologist could be called to
postpone mobilisation in participants with deteriorating condition while exercising
Modifications
The intervention protocol was not changed during the trial. The type and amount of mobilisation was
the same for infarct and haemorrhage
How well
Planned: the type and amount of mobilisation was similar to the VEM group but neither time nor dura-
tion was recorded
Actual: 5/32 VEM participants were not mobilised to protocol (3 were mobilised within 48 hours and 2
within 72 hours)
1/33 control participant had very delayed mobilisation at 85 hours. Median time from stroke to first mo-
bilisation in the VEM group was 13.1 hours (IQR 8.5 to 25.6) vs 33.3 hours (IQR 26.0 to 39.0) in controls (P
= 0.001). Neither frequency nor duration of mobilisation was recorded
Outcomes Outcomes were recorded at discharge and 3 months and included:
• good outcome (mRS of 0 to 2);• survival;• ADL score (Barthel index);• Complications were classified as:* stroke-related (recurrent stroke or intracerebral haemorrhage, transient ischaemic attack, post-
apoplectic epilepsy)* immobility-related (deep vein thrombosis, pulmonary embolism, bedsores, pneumonia, urinary
tract infection, and falls); and comorbidity-related (angina pectoris, myocardial infarction)* Hospital Anxiety and Depression Scale (HADS)
Notes Study recruited during 2007 and 2009 to 2010. Additional activity was not specified, but the interven-
tion group participants appeared to have received more out-of-bed activity in total, because it com-
menced earlier. Study was powered to include 246 participants, but stopped early because of slow re-
cruitment
9 participants were excluded after randomization when the diagnosis of stroke could not be confirmed
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "computer-generated, blocked, randomization procedures"
Allocation concealment
(selection bias)
Low risk Quote: "using opaque envelopes"
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk No specific comment
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Quote: "blinded assessment at the end of follow-up". Blinding was not present
for earlier outcomes
Incomplete outcome data
(attrition bias) 
Unclear risk A total of 12/65 (18%) patients randomized did not undergo 3-month follow-up
Sundseth 2012  (Continued)
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All outcomes
Selective reporting (re-
porting bias)
Unclear risk Primary outcome largely complete
Sundseth 2012  (Continued)
ADL: activities of daily living
BP: blood pressure
ICU: intensive care unit
IQR: interquartile range
MMSE: Mini Mental State Examinsation
mRS: modified Rankin scale
NIHSS: National Institutes of Health Stroke Scale
RCT: randomized controlled trial
rtPA: recombinant tissue plasminogen activator
VEM: very early mobilisation
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
AMOBES 2017 Commenced mobilisation after 48 hours
Asberg 1989 Insufficient details to confirm eligibility
Chu 2003 Timing not stated
Di Lauro 2003 No time difference between groups
Diserens 2010 Commenced mobilisation after 52 hours
Duan 2006 Timing not stated, additional psychotherapy and cognitive therapy
Fang 2001a Rehabilitation started 0-7 days after onset
Fang 2001b Rehabilitation started within 7 days of onset
Gong 2003 Timing not stated, not randomised
Gorbunov 2003 Insufficient details to confirm eligibility
Gu 2006 Timing not stated
Guan 2001 Timing not stated, confounded by additional psychotherapy and swallowing therapy
Hamrin 1982 Confounded by rehabilitation package (a large number of components of stroke unit care versus
none), pseudo-RCT
Hara 2001 Insufficient details to confirm eligibility
Huang 2001 Timing not stated
Huang 2003 Therapy was started < 1 day (ischaemic) or < 3 days (haemorrhagic)
Both types of participants were analysed together as a group
Contact attempted for further details - this was unsuccessful
Ishida 2001 Uncertain methods - major imbalance in groups
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Study Reason for exclusion
Kreisel 2005 No time difference of therapy between groups
Li 1999 No details on timing
Li 2003 Timing not stated
Li 2004 Timing not stated
Lin 2005 Timing not stated, confounded by additional psychotherapy, cognitive therapy
Liu 2001b Rehabilitation started at 3 days
Liu 2003b Rehabilitation started at 3-5 days
Liu 2004 No control < 48 hours, confounded by additional functional electrical stimulation
Marshall 2011 Insufficient details to confirm eligibility
Miskovic 2004 Insufficient details to confirm eligibility
Pan 2004 Timing not stated
Qian 2003 Timing not stated
Qian 2004 Timing not stated
Raicevic 2000 Timing not stated
Possibly passive therapies - not mobilisation
Richards 1993 Gait rehabilitation began in first 7 days
Sankara Kumaran 2013 Not formally randomised - purposive sampling
Song 2005 Timing not stated
Sun 2002 Insufficient details to confirm eligibility
Toyota 2001 Not clearly randomised (major imbalance in groups)
Truscott 1974 Not an RCT (observational)
Wang 2004 Timing uncertain - recruited after stabilisation
Wang 2005 Treatment within 1 week of onset
Wang 2006 Rehabilitation began at 10-20 days
Wu 2012 Delayed mobilisation - began on day 3
Xi 2003 Quasi-randomised, uncertain when out of bed
Xiao 2000 Delayed mobilisation - recruited at day 3
Xiao 2004 Timing not stated
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Study Reason for exclusion
Xie 2003a Began at 6-52 hours
Xue 2004 Intervention was the earlier delivery of a rehabilitation package that included mobilisation and
other therapies considered to potentially confound the results (speech therapy, swallowing thera-
py, psychological therapy including anti-depressants)
Xue 2006 Rehabilitation training began at 24 hours to 3 days
Xue 2008 Abstract only - no details on timing
Zeng 2004 Confounded by Chinese medicine, timing uncertain, quasi-randomised
Zhang 1998 Timing not stated
Zhang 2001 Began after 48 hours. Content uncertain
Zhao 2003 Uncertain timing: "as soon as state of illness was stable"
Zheng 2004a Began 3-7 days after stroke
RCT: randomised controlled trial
 
Characteristics of studies awaiting assessment [ordered by study ID]
 
Methods Quote "RCT"
Participants Early rehabilitation
Interventions Uncertain timing of onset
Outcomes  
Notes No further details
Izumi 2001 
 
 
Methods Prospective multicenter, randomized controlled study, comparing standard care (SC) vs standard
care plus early rehabilitation (VER: rehabilitation as soon as practical after randomization but with-
in 48 hours of symptom onset)
Participants Patients presenting < 48 hours after ICH (a first time ICH confirmed by MRI or CT) to the neurolo-
gy wards or rehabilitation units of participating hospitals with no contraindications to being mo-
bilised within 48 hours of stroke onset
Interventions VER: participants commenced rehabilitation within 48 hours of ICH onset
SC group commenced rehabilitation after 7 days. Within the first week this involved bed rest or sit-
ting in a chair. There is no showering or active rehabilitation with the main focus being medical
management.
Standard rehabilitation is usually commenced 1 week after stroke admission and continues un-
til discharge. It is performed by the participant's relatives under the guidance of medical staH and
Liu 2010e 
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usually involves 1) exercises of daily living, stretching exercises, and neuromuscular electric stim-
ulation, and 2) functional training in which the participants are instructed to do repetitive and sys-
tematic practice of tasks, such as stirring, grasping, and pointing
Outcomes Death, Barthel Index, SF-36, complications
Notes Although rehabilitation started within 48 hours it appears to have been initially 'passive'. As yet we
have been unable to obtain further details from the authors.
Liu 2010e  (Continued)
 
 
Methods Uncertain
Participants  
Interventions  
Outcomes  
Notes Abstract only - no details
Nilsson 2003 
 
 
Methods Uncertain
Participants Stroke patients within 24 hours
Interventions Early rehabilitation programme
Outcomes  
Notes Abstract only - no clinical outcomes
Skevin 2009 
 
 
Methods Single-blinded, RCT
Participants Early stroke
Interventions Early rehabilitation
Outcomes  
Notes Uncertain timing - trying to obtain full report
Song 2010 
 
 
Methods Uncertain
Xu 2001 
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Participants  
Interventions Early progressive physiotherapy
Outcomes  
Notes Abstract only
Xu 2001  (Continued)
 
 
Methods Uncertain
Participants  
Interventions  
Outcomes  
Notes Unable to obtain abstract
Zheng 2004 
 
 
Methods Uncertain
Participants  
Interventions  
Outcomes  
Notes No details available
Zielke 2003 
CT: computed tomography
ICH: intracerebral haemorrhage
MRI: magnetic resonance imaging
RCT: randomized controlled trial
 
Characteristics of ongoing studies [ordered by study ID]
 
Trial name or title AVERT-DOSE (Determining Optimal early rehabilitation after StrokE): a multi-arm covariate-adjust-
ed, response-adaptive randomized controlled trial
Methods Multicentre RCT
Participants Acute stroke patients (within 48 hours after stroke)
Interventions Early mobility rehabilitation protocols informed by the world’s first global trial of early rehabilita-
tion (AVERT)
AVERT-DOSE 2017 
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Outcomes Rankin score
Starting date Proposal at planning stage (2018 to 2022)
Contact information Julie Bernhardt, Florey Institute of Neuroscience and Mental Health, Melbourne, Australia
Notes  
AVERT-DOSE 2017  (Continued)
 
 
Trial name or title Effect of early and intensive rehabilitation on functional recovery after stroke
Methods Randomised parallel controlled comparison of 2 levels of early rehabilitation compared with con-
ventional rehabilitation
Participants Ischaemic stroke available for randomization within 24 hours of symptom onset
Interventions 2 levels of early rehabilitation compared with conventional rehabilitation
Outcomes MRI scan, NIHSS score, Fugl-Meyer Assessment Scale, Rivermead Motor Assessment Scale, Barthel
Index
Starting date  
Contact information  
Notes Yanna Tong, Department of Neurology , Beijing Luhe Hospital, Capital Medical University, Tongzhou
District, Beijing, China
tongyanna@163.com +86 13426364922
ChiCTR-ICR-15005992 
 
 
Trial name or title Efficacy and safety of very early rehabilitation within 24 hours of ischemic stroke with small-artery
occlusion
Methods RCT
Participants Inclusion criteria: patients 18 years or older consecutively admitted to the stroke unit within 24
hours after stroke onset were screened for recruitment. Patients with cerebral infarction and small
artery occlusion, defined according to the World Health Organization definition, were all included
Exclusion criteria: patients with mRS score ≥ 1 on admission; patients who were unable to com-
plete the baseline survey because of serious aphasia, language difficulties, or cognitive deficits; pa-
tient with other medical conditions, such as severe heart failure, acute coronary syndrome, which
prevented early rehabilitation; and patients who were unable to provide informed consent
Interventions Very early rehabilitation (within 24 hours) versus early rehabilitation
Outcomes NIHSS; Fugl-Meyer Assessment; Barthel Index; mRS
Starting date 2016
Contact information shoufengliu2010@163.com
ChiCTR-IPR-16008652 
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6 Jizhao Road, Jinnan District, Tianjin, China
Telephone: +86 022-59065182
Email: shoufengliu2010@163.com
Affiliation: Tianjin Huanhu Hospital
Notes Aim to recruit 2 groups of 50 participants each
ChiCTR-IPR-16008652  (Continued)
 
 
Trial name or title The effect of early mobilisation for stroke patients
Methods Randomised trial
Participants The effect of early mobilisation for stroke patients
Interventions VEM (within 48 hrs) vs early mobilisation (1 week) after stroke
Outcomes  
Starting date  
Contact information  
Notes Onging with at least 150 participants planned
ChiCTR-TRC-08000201 
mRS: modified Rankin scale
NIHSS: National Institutes of Health Stroke Scale
RCT: randomized controlled trial
VEM: very early mobilisation
 
 
D A T A   A N D   A N A L Y S E S
 
Comparison 1.   Very early mobilisation (VEM) versus standard care (measured at end of scheduled follow-up)
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Death or poor outcome 8 2542 Odds Ratio (M-H, Fixed, 95% CI) 1.08 [0.92, 1.26]
2 Death 8 2561 Odds Ratio (M-H, Fixed, 95% CI) 1.27 [0.95, 1.70]
3 Death or dependence
(modified Rankin score 3 to
6)
8 2542 Odds Ratio (M-H, Fixed, 95% CI) 1.08 [0.92, 1.26]
4 Death or institutional care 3 227 Odds Ratio (M-H, Fixed, 95% CI) 1.05 [0.53, 2.07]
5 Activities of daily living
(ADL) score
9 2630 Mean Difference (IV, Random, 95% CI) 1.94 [0.75, 3.13]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
6 Subjective Health Status
score
1 68 Mean Difference (IV, Random, 95% CI) 0.07 [-0.10, 0.23]
7 Able to walk 4 2255 Odds Ratio (M-H, Fixed, 95% CI) 1.00 [0.83, 1.21]
8 Mobility score 2 102 Std. Mean Difference (IV, Random, 95% CI) 0.14 [-0.27, 0.56]
9 Any complication: partic-
ipants who experienced at
least one complication
7 2778 Odds Ratio (M-H, Fixed, 95% CI) 0.88 [0.73, 1.06]
10 Type of complication: par-
ticipants who experienced at
least one complication
7   Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
10.1 Complications of immo-
bility
7 2778 Odds Ratio (M-H, Fixed, 95% CI) 0.79 [0.60, 1.03]
10.2 Other complications 6 2435 Odds Ratio (M-H, Fixed, 95% CI) 0.98 [0.78, 1.23]
11 Mood score 2 100 Std. Mean Difference (IV, Random, 95% CI) 0.07 [-0.33, 0.46]
12 Length of acute hospital
stay (days)
8 2551 Mean Difference (IV, Random, 95% CI) -1.44 [-2.28, -0.60]
 
 
Analysis 1.1.   Comparison 1 Very early mobilisation (VEM) versus standard care
(measured at end of scheduled follow-up), Outcome 1 Death or poor outcome.
Study or subgroup VEM Standard care Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
AVERT II 2008 24/38 22/33 2.88% 0.86[0.32,2.28]
AVERT III 2015 558/1038 520/1045 79.46% 1.17[0.99,1.39]
Chippala 2015a 6/40 22/40 6.2% 0.14[0.05,0.42]
Chippala 2015b 8/24 12/25 2.6% 0.54[0.17,1.72]
Langhorne 2010 4/16 9/16 2.24% 0.26[0.06,1.16]
Poletto 2015 8/16 8/17 1.29% 1.13[0.29,4.41]
SEVEL 2016 15/63 17/75 3.92% 1.07[0.48,2.36]
Sundseth 2012 17/27 12/29 1.42% 2.41[0.82,7.06]
   
Total (95% CI) 1262 1280 100% 1.08[0.92,1.26]
Total events: 640 (VEM), 622 (Standard care)  
Heterogeneity: Tau2=0; Chi2=21.73, df=7(P=0); I2=67.79%  
Test for overall effect: Z=0.92(P=0.36)  
Favours VEM 100.1 50.2 20.5 1 Favours standard care
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Analysis 1.2.   Comparison 1 Very early mobilisation (VEM) versus standard
care (measured at end of scheduled follow-up), Outcome 2 Death.
Study or subgroup VEM Standard care Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
AVERT II 2008 8/38 3/33 3.18% 2.67[0.64,11.03]
AVERT III 2015 88/1048 72/1050 82.67% 1.25[0.9,1.72]
Chippala 2015a 0/40 0/40   Not estimable
Chippala 2015b 0/24 1/25 1.81% 0.33[0.01,8.59]
Langhorne 2010 0/16 1/16 1.83% 0.31[0.01,8.28]
Poletto 2015 2/18 2/19 2.17% 1.06[0.13,8.47]
SEVEL 2016 3/63 6/75 6.55% 0.57[0.14,2.4]
Sundseth 2012 7/27 2/29 1.79% 4.72[0.89,25.21]
   
Total (95% CI) 1274 1287 100% 1.27[0.95,1.7]
Total events: 108 (VEM), 87 (Standard care)  
Heterogeneity: Tau2=0; Chi2=5.99, df=6(P=0.42); I2=0%  
Test for overall effect: Z=1.61(P=0.11)  
Favours VEM 100.1 50.2 20.5 1 Favours standard care
 
 
Analysis 1.3.   Comparison 1 Very early mobilisation (VEM) versus standard care (measured at
end of scheduled follow-up), Outcome 3 Death or dependence (modified Rankin score 3 to 6).
Study or subgroup VEM Standard care Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
AVERT II 2008 24/38 22/33 2.88% 0.86[0.32,2.28]
AVERT III 2015 558/1038 520/1045 79.46% 1.17[0.99,1.39]
Chippala 2015a 6/40 22/40 6.2% 0.14[0.05,0.42]
Chippala 2015b 8/24 12/25 2.6% 0.54[0.17,1.72]
Langhorne 2010 4/16 9/16 2.24% 0.26[0.06,1.16]
Poletto 2015 8/16 8/17 1.29% 1.13[0.29,4.41]
SEVEL 2016 15/63 17/75 3.92% 1.07[0.48,2.36]
Sundseth 2012 17/27 12/29 1.42% 2.41[0.82,7.06]
   
Total (95% CI) 1262 1280 100% 1.08[0.92,1.26]
Total events: 640 (VEM), 622 (Standard care)  
Heterogeneity: Tau2=0; Chi2=21.73, df=7(P=0); I2=67.79%  
Test for overall effect: Z=0.92(P=0.36)  
Favours VEM 100.1 50.2 20.5 1 Favours standard care
 
 
Analysis 1.4.   Comparison 1 Very early mobilisation (VEM) versus standard care
(measured at end of scheduled follow-up), Outcome 4 Death or institutional care.
Study or subgroup VEM Standard care Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
AVERT II 2008 9/38 8/33 40.46% 0.97[0.33,2.89]
Langhorne 2010 3/16 6/16 30.18% 0.38[0.08,1.93]
SEVEL 2016 9/58 6/66 29.36% 1.84[0.61,5.52]
   
Favours VEM 1000.01 100.1 1 Favours standard care
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Study or subgroup VEM Standard care Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Total (95% CI) 112 115 100% 1.05[0.53,2.07]
Total events: 21 (VEM), 20 (Standard care)  
Heterogeneity: Tau2=0; Chi2=2.5, df=2(P=0.29); I2=20.12%  
Test for overall effect: Z=0.13(P=0.89)  
Favours VEM 1000.01 100.1 1 Favours standard care
 
 
Analysis 1.5.   Comparison 1 Very early mobilisation (VEM) versus standard care
(measured at end of scheduled follow-up), Outcome 5 Activities of daily living (ADL) score.
Study or subgroup VEM Standard care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
AVERT II 2008 38 18.5 (12.9) 33 16.5 (7.9) 4.34% 2[-2.91,6.91]
AVERT III 2015 943 16.2 (5.8) 965 16.2 (6) 16.2% 0[-0.53,0.53]
Chippala 2015a 40 17.7 (2) 40 15.1 (2.3) 15.14% 2.6[1.66,3.54]
Langhorne 2010 16 18.1 (3.9) 15 12.4 (8.3) 4.75% 5.7[1.09,10.31]
Morreale 2016 CTE 110 17.2 (1.4) 60 14.6 (1) 16.48% 2.6[2.24,2.96]
Morreale 2016 PNF 110 17.8 (0.4) 60 14.2 (1.8) 16.32% 3.6[3.14,4.06]
Poletto 2015 16 17 (10) 17 16 (5) 3.71% 1[-4.45,6.45]
SEVEL 2016 57 19.3 (1.6) 66 18.1 (4.5) 14.43% 1.2[0.04,2.36]
Sundseth 2012 18 16.8 (5.1) 26 17.2 (4) 8.64% -0.4[-3.21,2.41]
   
Total *** 1348   1282   100% 1.94[0.75,3.13]
Heterogeneity: Tau2=2.2; Chi2=115.19, df=8(P<0.0001); I2=93.06%  
Test for overall effect: Z=3.2(P=0)  
Favours standard care 52.5-5 -2.5 0 Favours VEM
 
 
Analysis 1.6.   Comparison 1 Very early mobilisation (VEM) versus standard care
(measured at end of scheduled follow-up), Outcome 6 Subjective Health Status score.
Study or subgroup VEM Standard care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
AVERT II 2008 36 0.4 (0.4) 32 0.3 (0.3) 100% 0.07[-0.1,0.23]
   
Total *** 36   32   100% 0.07[-0.1,0.23]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.8(P=0.42)  
Favours standard care 10050-100 -50 0 Favours VEM
 
 
Analysis 1.7.   Comparison 1 Very early mobilisation (VEM) versus standard
care (measured at end of scheduled follow-up), Outcome 7 Able to walk.
Study or subgroup VEM Standard care Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
AVERT II 2008 22/38 16/32 3.42% 1.38[0.53,3.54]
Favours VEM 100.1 50.2 20.5 1 Favours standard care
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Study or subgroup VEM Standard care Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
AVERT III 2015 784/1051 796/1049 94.75% 0.93[0.77,1.14]
Langhorne 2010 14/16 10/16 0.59% 4.2[0.7,25.26]
Sundseth 2012 11/25 5/28 1.24% 3.61[1.04,12.6]
   
Total (95% CI) 1130 1125 100% 1[0.83,1.21]
Total events: 831 (VEM), 827 (Standard care)  
Heterogeneity: Tau2=0; Chi2=7.43, df=3(P=0.06); I2=59.61%  
Test for overall effect: Z=0.01(P=0.99)  
Favours VEM 100.1 50.2 20.5 1 Favours standard care
 
 
Analysis 1.8.   Comparison 1 Very early mobilisation (VEM) versus standard
care (measured at end of scheduled follow-up), Outcome 8 Mobility score.
Study or subgroup VEM Standard care Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
AVERT II 2008 38 10 (6.8) 33 10 (5.7) 68.51% 0[-0.47,0.47]
Langhorne 2010 16 6.5 (5.5) 15 4.3 (3.7) 31.49% 0.45[-0.26,1.17]
   
Total *** 54   48   100% 0.14[-0.27,0.56]
Heterogeneity: Tau2=0.01; Chi2=1.09, df=1(P=0.3); I2=8.09%  
Test for overall effect: Z=0.68(P=0.5)  
Favours standard care 21-2 -1 0 Favours VEM
 
 
Analysis 1.9.   Comparison 1 Very early mobilisation (VEM) versus standard care (measured at end of
scheduled follow-up), Outcome 9 Any complication: participants who experienced at least one complication.
Study or subgroup VEM Standard care Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
AVERT II 2008 14/38 15/33 4.3% 0.7[0.27,1.81]
AVERT III 2015 201/1054 208/1050 71.44% 0.95[0.77,1.18]
Langhorne 2010 5/16 10/16 2.91% 0.27[0.06,1.18]
Morreale 2016 31/220 24/120 11.3% 0.66[0.36,1.18]
Poletto 2015 3/18 2/19 0.69% 1.7[0.25,11.59]
SEVEL 2016 15/63 23/75 6.78% 0.71[0.33,1.51]
Sundseth 2012 18/27 19/29 2.59% 1.05[0.35,3.19]
   
Total (95% CI) 1436 1342 100% 0.88[0.73,1.06]
Total events: 287 (VEM), 301 (Standard care)  
Heterogeneity: Tau2=0; Chi2=5.05, df=6(P=0.54); I2=0%  
Test for overall effect: Z=1.34(P=0.18)  
Favours VEM 100.1 50.2 20.5 1 Favours standard care
 
 
Very early versus delayed mobilisation aer stroke (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
62
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Analysis 1.10.   Comparison 1 Very early mobilisation (VEM) versus standard care (measured at end of scheduled
follow-up), Outcome 10 Type of complication: participants who experienced at least one complication.
Study or subgroup VEM Standard care Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
1.10.1 Complications of immobility  
AVERT II 2008 5/38 11/33 8.64% 0.3[0.09,0.99]
AVERT III 2015 54/1054 53/1050 42.58% 1.02[0.69,1.5]
Langhorne 2010 2/16 7/16 5.18% 0.18[0.03,1.09]
Morreale 2016 31/220 24/120 22.55% 0.66[0.36,1.18]
Poletto 2015 3/18 2/19 1.37% 1.7[0.25,11.59]
SEVEL 2016 15/63 23/75 13.52% 0.71[0.33,1.51]
Sundseth 2012 15/27 17/29 6.16% 0.88[0.31,2.55]
Subtotal (95% CI) 1436 1342 100% 0.79[0.6,1.03]
Total events: 125 (VEM), 137 (Standard care)  
Heterogeneity: Tau2=0; Chi2=7.81, df=6(P=0.25); I2=23.18%  
Test for overall effect: Z=1.72(P=0.09)  
   
1.10.2 Other complications  
AVERT II 2008 9/38 4/33 2.19% 2.25[0.62,8.14]
AVERT III 2015 147/1054 155/1050 89.74% 0.94[0.73,1.19]
Langhorne 2010 3/16 3/16 1.64% 1[0.17,5.9]
Poletto 2015 0/18 0/19   Not estimable
SEVEL 2016 9/62 10/73 5.27% 1.07[0.4,2.83]
Sundseth 2012 3/27 2/29 1.15% 1.69[0.26,10.97]
Subtotal (95% CI) 1215 1220 100% 0.98[0.78,1.23]
Total events: 171 (VEM), 174 (Standard care)  
Heterogeneity: Tau2=0; Chi2=2.1, df=4(P=0.72); I2=0%  
Test for overall effect: Z=0.16(P=0.87)  
Test for subgroup differences: Chi2=1.46, df=1 (P=0.23), I2=31.43%  
Favours VEM 100.1 50.2 20.5 1 Favours standard care
 
 
Analysis 1.11.   Comparison 1 Very early mobilisation (VEM) versus standard
care (measured at end of scheduled follow-up), Outcome 11 Mood score.
Study or subgroup VEM Standard care Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
AVERT II 2008 21 12.4 (9.1) 23 12.6 (6.6) 44.04% -0.02[-0.62,0.57]
Sundseth 2012 27 11 (9.8) 29 9.9 (5.3) 55.96% 0.14[-0.39,0.66]
   
Total *** 48   52   100% 0.07[-0.33,0.46]
Heterogeneity: Tau2=0; Chi2=0.16, df=1(P=0.69); I2=0%  
Test for overall effect: Z=0.34(P=0.74)  
Favours VEM 52.5-5 -2.5 0 Favours standard care
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Analysis 1.12.   Comparison 1 Very early mobilisation (VEM) versus standard care (measured
at end of scheduled follow-up), Outcome 12 Length of acute hospital stay (days).
Study or subgroup VEM Standard care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
AVERT II 2008 38 8.6 (9.4) 33 9.8 (8) 4.01% -1.2[-5.25,2.85]
AVERT III 2015 1052 11.6 (16.3) 1050 12 (16.1) 21.75% -0.4[-1.79,0.99]
Chippala 2015a 40 8 (1.4) 40 10.3 (3.4) 26.84% -2.25[-3.39,-1.11]
Chippala 2015b 24 8.7 (1.4) 25 11.2 (3.2) 21.96% -2.5[-3.87,-1.13]
Langhorne 2010 16 11.3 (9.9) 16 14.9 (15.3) 0.88% -3.6[-12.53,5.33]
Poletto 2015 18 9 (6.4) 19 13 (15) 1.28% -4[-11.36,3.36]
SEVEL 2016 58 9.8 (4.9) 66 10.5 (6.1) 13.92% -0.7[-2.64,1.24]
Sundseth 2012 27 10.2 (4.2) 29 9.9 (5.3) 9.38% 0.3[-2.2,2.8]
   
Total *** 1273   1278   100% -1.44[-2.28,-0.6]
Heterogeneity: Tau2=0.35; Chi2=9.44, df=7(P=0.22); I2=25.84%  
Test for overall effect: Z=3.35(P=0)  
Favours VEM 52.5-5 -2.5 0 Favours standard care
 
 
Comparison 2.   Very early mobilisation versus standard care (results at 3 months)
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Death or poor outcome 8 2542 Odds Ratio (M-H, Fixed, 95% CI) 1.08 [0.92, 1.26]
2 Death 8 2570 Odds Ratio (M-H, Fixed, 95% CI) 1.27 [0.95, 1.70]
3 Death or dependence (modified
Rankin score 3 to 6)
8 2542 Odds Ratio (M-H, Fixed, 95% CI) 1.08 [0.92, 1.26]
4 Death or institutional care 3 227 Odds Ratio (M-H, Fixed, 95% CI) 1.05 [0.53, 2.07]
5 Activities of daily living (ADL) score 9 2634 Mean Difference (IV, Random, 95% CI) 0.75 [0.01, 1.49]
 
 
Analysis 2.1.   Comparison 2 Very early mobilisation versus standard
care (results at 3 months), Outcome 1 Death or poor outcome.
Study or subgroup VEM Standard care Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
AVERT II 2008 24/38 22/33 2.88% 0.86[0.32,2.28]
AVERT III 2015 558/1038 520/1045 79.46% 1.17[0.99,1.39]
Chippala 2015a 6/40 22/40 6.2% 0.14[0.05,0.42]
Chippala 2015b 8/24 12/25 2.6% 0.54[0.17,1.72]
Langhorne 2010 4/16 9/16 2.24% 0.26[0.06,1.16]
Poletto 2015 8/16 8/17 1.29% 1.13[0.29,4.41]
SEVEL 2016 15/63 17/75 3.92% 1.07[0.48,2.36]
Sundseth 2012 17/27 12/29 1.42% 2.41[0.82,7.06]
   
Favours VEM 100.1 50.2 20.5 1 Favours standard care
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Study or subgroup VEM Standard care Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Total (95% CI) 1262 1280 100% 1.08[0.92,1.26]
Total events: 640 (VEM), 622 (Standard care)  
Heterogeneity: Tau2=0; Chi2=21.73, df=7(P=0); I2=67.79%  
Test for overall effect: Z=0.92(P=0.36)  
Favours VEM 100.1 50.2 20.5 1 Favours standard care
 
 
Analysis 2.2.   Comparison 2 Very early mobilisation versus standard care (results at 3 months), Outcome 2 Death.
Study or subgroup VEM Standard care Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
AVERT II 2008 8/38 3/33 3.18% 2.67[0.64,11.03]
AVERT III 2015 88/1048 72/1050 82.56% 1.25[0.9,1.72]
Chippala 2015a 0/40 0/40   Not estimable
Chippala 2015b 0/24 1/25 1.81% 0.33[0.01,8.59]
Langhorne 2010 0/16 1/16 1.82% 0.31[0.01,8.28]
Poletto 2015 2/18 2/19 2.17% 1.06[0.13,8.47]
SEVEL 2016 3/63 6/75 6.54% 0.57[0.14,2.4]
Sundseth 2012 7/32 2/33 1.93% 4.34[0.83,22.77]
   
Total (95% CI) 1279 1291 100% 1.27[0.95,1.7]
Total events: 108 (VEM), 87 (Standard care)  
Heterogeneity: Tau2=0; Chi2=5.74, df=6(P=0.45); I2=0%  
Test for overall effect: Z=1.59(P=0.11)  
Favours VEM 100.1 50.2 20.5 1 Favours standard care
 
 
Analysis 2.3.   Comparison 2 Very early mobilisation versus standard care (results
at 3 months), Outcome 3 Death or dependence (modified Rankin score 3 to 6).
Study or subgroup VEM Standard care Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
AVERT II 2008 24/38 22/33 2.88% 0.86[0.32,2.28]
AVERT III 2015 558/1038 520/1045 79.46% 1.17[0.99,1.39]
Chippala 2015a 6/40 22/40 6.2% 0.14[0.05,0.42]
Chippala 2015b 8/24 12/25 2.6% 0.54[0.17,1.72]
Langhorne 2010 4/16 9/16 2.24% 0.26[0.06,1.16]
Poletto 2015 8/16 8/17 1.29% 1.13[0.29,4.41]
SEVEL 2016 15/63 17/75 3.92% 1.07[0.48,2.36]
Sundseth 2012 17/27 12/29 1.42% 2.41[0.82,7.06]
   
Total (95% CI) 1262 1280 100% 1.08[0.92,1.26]
Total events: 640 (VEM), 622 (Standard care)  
Heterogeneity: Tau2=0; Chi2=21.73, df=7(P=0); I2=67.79%  
Test for overall effect: Z=0.92(P=0.36)  
Favours VEM 100.1 50.2 20.5 1 Favours standard care
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Analysis 2.4.   Comparison 2 Very early mobilisation versus standard
care (results at 3 months), Outcome 4 Death or institutional care.
Study or subgroup VEM Standard care Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
AVERT II 2008 9/38 8/33 40.46% 0.97[0.33,2.89]
Langhorne 2010 3/16 6/16 30.18% 0.38[0.08,1.93]
SEVEL 2016 9/58 6/66 29.36% 1.84[0.61,5.52]
   
Total (95% CI) 112 115 100% 1.05[0.53,2.07]
Total events: 21 (VEM), 20 (Standard care)  
Heterogeneity: Tau2=0; Chi2=2.5, df=2(P=0.29); I2=20.12%  
Test for overall effect: Z=0.13(P=0.89)  
Favours VEM 1000.01 100.1 1 Favours standard care
 
 
Analysis 2.5.   Comparison 2 Very early mobilisation versus standard care
(results at 3 months), Outcome 5 Activities of daily living (ADL) score.
Study or subgroup VEM Standard care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
AVERT II 2008 38 18.5 (12.9) 33 16.5 (7.9) 2.06% 2[-2.91,6.91]
AVERT III 2015 943 16.2 (5.8) 965 16.2 (6) 19.19% 0[-0.53,0.53]
Chippala 2015a 40 17.7 (2) 40 15.1 (2.3) 15.8% 2.6[1.66,3.54]
Langhorne 2010 16 18.1 (3.9) 15 12.4 (8.3) 2.3% 5.7[1.09,10.31]
Morreale 2016 CTE 110 12.4 (1.4) 60 12.6 (1) 20.23% -0.2[-0.56,0.16]
Morreale 2016 PNF 110 12.6 (1.2) 60 12.4 (1.8) 19.34% 0.2[-0.31,0.71]
Poletto 2015 18 17 (10) 19 16 (5) 1.89% 1[-4.14,6.14]
SEVEL 2016 57 19.3 (1.6) 66 18.1 (4.5) 13.96% 1.2[0.04,2.36]
Sundseth 2012 18 16.8 (5.1) 26 17.2 (4) 5.23% -0.4[-3.21,2.41]
   
Total *** 1350   1284   100% 0.75[0.01,1.49]
Heterogeneity: Tau2=0.67; Chi2=39.07, df=8(P<0.0001); I2=79.53%  
Test for overall effect: Z=1.98(P=0.05)  
Favours standard care 52.5-5 -2.5 0 Favours VEM
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Trial Stated aim for
mobilisation
activity
Participant
median age
(% male)
Stroke
severity
(moderate
or severe
stroke)
Early mobili-
sation TTFM
(hours; median;
IQR)
Usual care TTFM
(hours; median;
IQR)
Average fre-
quency of
mobilisation
events per day
(early vs usual
care)
Average amount of mobilisation activi-
ty (early vs usual care)
AVERT II
2008
Earlier and
more
75 yrs (54%) 57% 18.1 (12.8 to 21.5) 30.8 (23.0 to 39.9) 2 vs 0 167 vs 69 mins/admission mobilisation ac-
tivity
AVERT III
2015
Earlier and
more
73 yrs (39%) 45% 18.5 (12.8 to 22.3) 22.4 (16.5 to 29.3) 6.5 vs 3 31 vs 10 mins/day mobilisation activity
Chippala
2015a
Earlier and
more
60 yrs (52%) 68% 18 (16.6 to 19.8) 30.5 (29.0 to 35.0) Not stated Extra 5 to 30 mins/day out-of-bed activity
Chippala
2015b
Earlier and
more
64 yrs (57%) 44% 18 (16.6 to 19.8) 30.5 (29.0 to 35.0) Not stated Extra 5 to 30 mins/day out-of-bed activity
Langhorne
2010
Earlier and
more
68 yrs (50%) 28% 27.3 (26.0 to 29.0) 32.0 (22.5 to 47.3) Not stated More early mobilisation, standing or walk-
ing, recorded using activity monitors (P =
0.02)
Morreale
2016
Earlier 64 yrs (72%) < 89% < 24 96 Not stated 60 mins/day more early mobilisation
group for first 4 days
Poletto 2015 Earlier and
more
65 yrs (35%) < 70% 43 72 0.54 vs 0.03 Extra 30 mins/day out-of-bed activity
SEVEL 2016 Earlier 70 yrs (64%) 44% 25.9 (22.5 to 29.3) 71.5 (68.1 to 74.9) Not stated 83.7 vs 56.6 mins/day
Sundseth
2012
Earlier 77 yrs (45%) 34% 13.1 (8.5 to 25.6) 33.3 (26.0 to 39.0) Not stated Not stated
Table 1.   Summary of patient and treatment characteristics (included trials) 
IQR: interquartile range
mins: minutes
TTFM: time from stroke to first mobilisation activity (hours)
vs: versus
yrs: years
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Very early mobilisation group TTFM characteristicsUsual care group TTFM characteristics
12 hours 18 hours 24 hours > 30
hours
> 48
hours
12 hours - - - - -
18 hours - - - - -
24 hours - AVERT III 2015 (2014 ppts) - - -
> 30 hours Sundseth
2012 (65
ppts)
AVEAVERT II 2008; Chip-
pala 2015a; Chippala
2015b (211 ppts)
Langhorne
2010 (32 ppts)
- -
> 48 hours     SEVEL 2016 167
ppts)
Poletto
2015 (39
ppts)
-
Table 2.   Time-to-first mobilisation (TTFM) comparisons (included trials)  (Continued)
ppts = participants
Table shows Time-to-first mobilisation (TTFM) in each trial with the very early mobilisation TTFM group in the columns and usual care TTFM
in the rows. The number of trials (participants) in each direct comparison of TTFM are also shown. For example Sundseth 2012 compared
TTFM of approximately 12 hours with > 30 hours and included 65 participants.
We did not include data from Morreale 2016 in this analysis as we did not have access to dichotomous data on poor outcome or death.
 
 
TTFM cat-
egory
TTFM recorded in
the trials (median;
IQR)
Direct
compari-
son
(OR)
Indirect
compari-
son
(OR)
Log difference (95%
CI) between direct
and indirect compar-
isons
P value of dif-
ference be-
tween direct
and indirect
comparisons
Network meta-analy-
sis
(OR and 95% CI)
12 hours 13 (9 to 26) NA 6.62 NA NA 6.61 (1.36 to 32.09)
18 hours 18 (13 to 21) 1.17 0.80 -0.39 (-2.09 to 1.31) 0.65 1.07 (0.53 to 2.19)
24 hours 26 (22 to 29) 1.00 (ref-
erence)
Reference Reference Reference Reference
> 30 hours 32 (26 to 40) 3.86 2.46 0.45 (-1.50 to 2.41) 0.65 2.74 (1.18 to 6.37)
> 48 hours 72 (68 to 75) 0.94 3.03 -1.18 (-3.33 to 0.98) 0.28 1.29 (0.50 to 3.37)
Table 3.   Inconsistency table for poor outcome (death or dependency at 3 months) 
The first two columns show the TTFM category plus the actual recorded TTFM for that category.
The next two columns show the odds ratio of a poor outcome for the direct and indirect comparison of the TTFM category, with 24 hours
as the reference category.
The fi&h column shows the log difference, and the sixth shows the P value, between the two odds ratio estimates.
The final column shows the network meta-analysis results, which combine the direct and indirect evidence.
CI: confidence interval
IQR: interquartile range
NA: no data available
OR: odds ratio
TTFM: time-to-first mobilisation
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TTFM cat-
egory
TTFM recorded in the
trials (median; IQR)
Direct
compari-
son
(OR)
Indirect
compari-
son
(OR)
Log difference (95%
CI) between direct
and indirect com-
parisons
P value of dif-
ference be-
tween direct
and indirect
comparisons
Network meta-analy-
sis
(OR and 95% CI)
12 hours 13 (9 to 26) NA 4.18 NA NA 4.17 (0.57 to 30.7)
18 hours 18 (13 to 21) 1.25 4.35 1.25 (-1.16 to 3.66) 0.31 1.27 (0.92 to 1.76)
24 hours 26 (22 to 29) 1.00 (ref-
erence)
- - - -
> 30 hours 32 (26 to 40) 3.19 0.82 1.36 (-2.12 to 4.84) 0.44 0.96 (0.32 to 2.92)
> 48 hours 72 (68 to 75) 1.73 0.77 0.81 (-1.99 to 3.62) 0.57 1.41 (0.41 to 4.82)
Table 4.   Inconsistency table for death at 3 months 
The first two columns show the TTFM category plus the actual recorded TTFM for that category.
The next two columns show the odds ratio of a poor outcome for the direct and indirect comparison of the TTFM category, with 24 hours
as the reference.
The fi&h column shows the log difference, and the sixth shows the P value, between the two odds ratio estimates.
The final column shows the network meta-analysis results, which combine the direct and indirect evidence.
CI: confidence interval
IQR: interquartile range
NA: no data available
OR: odds ratio
TTFM: time-to-first mobilisation
 
 
Intervention
TTFM
Compari-
son TTFM
(reference
treatment)
No. of stud-
ies (partici-
pants) with
direct com-
parison evi-
dence
Direct comparison
evidence
OR (95% CI)
Quality
of the ev-
idence
(GRADE) for
direct com-
parisons
Direct plus indirect evi-
dence (NMA)
OR (95% CI)
Quality
of the ev-
idence
(GRADE) for
NMA
Poor outcome
12 hours 24 hours 0 NA NA 6.61 (1.36 to 32.1) Low a, b
18 hours 24 hours 1 (2104) 1.17 (0.99 to 1.39) Moderate c 1.07 (0.53 to 2.19) Low b, c
30 to 48 hours 24 hours 1 (32) 3.85 (0.86 to 16.7) Low b, e 2.74 (1.18 to 6.37) Low b, e
More than 48
hours
24 hours 1 (167) 0.94 (0.42 to 2.08) Low d, e 1.29 (0.50 to 3.37) Low b, e
Death
12 hours 24 hours 0 NA NA 4.17 (0.57 to 30.7) Low a, b
18 hours 24 hours 1 (2104) 1.25 (0.90 to 1.72) Moderate c 1.27 (0.92 to 1.76) Low b, c
Table 5.   'Summary of findings' table for network meta-analysis (NMA) 
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30 to 48 hours 24 hours 1 (32) 3.03 (0.12 to 100) Low b, e 0.96 (0.32 to 2.92) Low b, e
More than 48
hours
24 hours 1 (167) 1.75 (0.42 to 7.14) Low b, e 1.41 (0.41 to 4.82) Low b, e
Table 5.   'Summary of findings' table for network meta-analysis (NMA)  (Continued)
a Main trial in the loop was small and had missing data
b Downgraded for imprecision
c Based on a single large trial
d Based on single small trial
e Uncertain blinding of follow up
 
 
A P P E N D I C E S
Appendix 1. CENTRAL and DARE search strategy (the Cochrane Library)
#1 [mh ^"cerebrovascular disorders"] or [mh "basal ganglia cerebrovascular disease"] or [mh "brain ischemia"] or [mh "carotid artery
diseases"] or [mh "cerebral small vessel diseases"] or [mh "intracranial arterial diseases"] or [mh "intracranial embolism and thrombosis"]
or [mh "intracranial hemorrhages"] or [mh ^ stroke] or [mh "brain infarction"] or [mh ^ "stroke, lacunar"] or [mh ^ "vasospasm, intracranial"]
or [mh ^"vertebral artery dissection"]
#2 (stroke* or poststroke or apoplex* or cerebral next vasc* or brain next vasc* or cerebrovasc* or cva* or SAH):ti,ab
#3 ((brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or supratentorial or "middle
cerebral artery" or MCA* or "anterior circulation" or "posterior circulation" or "basilar artery" or "vertebral artery" or "space-occupying")
near/5 (isch*emi* or infarct* or thrombo* or emboli* or occlus* or hypoxi*)):ti,ab
#4 ((brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or infratentorial
or supratentorial or basal next gangli* or putaminal or putamen or "posterior fossa" or hemispher* or subarachnoid) near/5 (hemorrhag*
or haemorrhage* or hematoma* or haematoma* or bleed*)):ti,ab
#5 [mh ^hemiplegia] or [mh paresis]
#6 (hemipleg* or hemipar* or paresis or paretic):ti,ab
#7 #1 or #2 or #3 or #4 or #5 or #6
#8 [mh ^"bed rest"] or [mh ^immobilization] or [mh ^rest]
#9 (bed rest or bed-rest or bedrest or bed bound or bed-bound or bedbound):ti,ab
#10 ((confined or restrict* or immobili*) near/5 bed):ti,ab
#11 [mh ^"early ambulation"]
#12 [mh ^"Physical Therapy Modalities"] or [mh ^"Physical Therapy (Specialty)"]
#13 [mh ^rehabilitation] or [mh ^"activities of daily living"] or [mh ^"recovery of function"]
#14 [mh ^movement] or [mh ^locomotion] or [mh ^walking] or [mh ^"motor activity"]
#15 [mh ^"exercise movement techniques"] or [mh ^exercise] or [mh ^"exercise therapy"]
#16 (stroke unit* or "mobility protocol"):ti,ab
#17 #12 or #13 or #14 or #15 or #16
#18 [mh ^"time factors"] or [mh ^time] or early:ti,ab
#19 #17 and #18
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#20 ((early or earlie* or accelerat* or immediat* or "fast-track" or timing or rapid*) near/5 (mobil* or ambulat* or rehab* or physiotherapy
or "physical therapy" or "physical activity" or movement or sitting or standing or walking or semi next recumb* or "out of bed")):ti,ab
#21 #8 or #9 or #10 or #11 or #19 or #20
#22 #7 and #21
#23 [mh ^"cerebrovascular disorders" [mj]/NU,RH,TH] or [mh "basal ganglia cerebrovascular disease" [mj]/NU,RH,TH] or [mh "brain is-
chemia" [mj]/NU,RH,TH] or [mh "carotid artery diseases" [mj]/NU,RH,TH] or [mh "cerebral small vessel diseases" [mj]/NU,RH,TH] or [mh
"intracranial arterial diseases" [mj]/NU,RH,TH] or [mh "intracranial embolism and thrombosis" [mj]/NU,RH,TH] or [mh "intracranial hem-
orrhages" [mj]/NU,RH,TH] or [mh ^ stroke [mj]/NU,RH,TH] or [mh "brain infarction" [mj]/NU,RH,TH] or [mh "stroke, lacunar" [mj]/NU,RH,TH]
or [mh ^"vasospasm, intracranial" [mj]/NU,RH,TH] or [mh ^"vertebral artery dissection" [mj]/NU,RH,TH]
#24 #18 and #23
#25 #22 or #24
Appendix 2. MEDLINE search strategy
MEDLINE 2016
1. cerebrovascular disorders/ or exp basal ganglia cerebrovascular disease/ or exp brain ischemia/ or exp carotid artery diseases/ or exp
cerebral small vessel diseases/ or exp intracranial arterial diseases/ or exp "intracranial embolism and thrombosis"/ or exp intracranial
hemorrhages/ or stroke/ or exp brain infarction/ or stroke, lacunar/ or vasospasm, intracranial/ or vertebral artery dissection/
2. (stroke$ or poststroke or apoplex$ or cerebral vasc$ or brain vasc$ or cerebrovasc$ or cva$ or SAH).tw.
3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or middle
cerebral artery or MCA$ or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying) adj5 (isch?
emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or hypoxi$)).tw.
4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraparenchymal or intraventricular or infratentorial
or supratentorial or basal gangli$ or putaminal or putamen or posterior fossa or hemispher$ or subarachnoid) adj5 (h?emorrhag$ or h?
ematoma$ or bleed$)).tw.
5. hemiplegia/ or exp paresis/
6. (hemipleg$ or hemipar$ or paresis or paretic).tw.
7. or/1-6
8. bed rest/ or immobilization/ or rest/
9. (bed rest or bed-rest or bedrest or bed bound or bed-bound or bedbound).tw.
10. ((confined or restricted or immobili$) adj5 bed).tw.
11. early ambulation/
12. Physical Therapy Modalities/ or "Physical Therapy (Specialty)"/
13. rehabilitation/ or "activities of daily living"/ or recovery of function/
14. movement/ or locomotion/ or walking/ or motor activity/
15. exercise movement techniques/ or exercise/ or exercise therapy/
16. (stroke unit$ or mobility protocol).tw.
17. 12 or 13 or 14 or 15 or 16
18. time factors/ or time/ or early.tw.
19. 17 and 18
20. ((early or earlie$ or accelerat$ or immediat$ or fast-track or timing or rapid$) adj5 (mobil$ or ambulat$ or rehab$ or physiotherapy or
physical therapy or physical activity or movement or sitting or standing or walking or semi-recumb$ or out of bed)).tw.
Very early versus delayed mobilisation aer stroke (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
71
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
21. 8 or 9 or 10 or 11 or 19 or 20
22. 7 and 21
23. *cerebrovascular disorders/nu, rh or exp *basal ganglia cerebrovascular disease/nu, rh or exp *brain ischemia/nu, rh or exp *carotid
artery diseases/nu, rh or exp *cerebral small vessel diseases/nu, rh or exp *intracranial arterial diseases/nu, rh or exp *"intracranial em-
bolism and thrombosis"/nu, rh or exp *intracranial hemorrhages/nu, rh or *stroke/nu, rh or exp *brain infarction/nu, rh or *stroke, lacu-
nar/nu, rh or *vasospasm, intracranial/nu, rh or *vertebral artery dissection/nu, rh
24. 18 and 23
25. 22 or 24
26. Randomized Controlled Trials as Topic/
27. random allocation/
28. Controlled Clinical Trials as Topic/
29. control groups/
30. clinical trials as topic/
31. double-blind method/
32. single-blind method/
33. randomized controlled trial.pt.
34. controlled clinical trial.pt.
35. clinical trial.pt.
36. (random$ or RCT or RCTs).tw.
37. (controlled adj5 (trial$ or stud$)).tw.
38. (clinical$ adj5 trial$).tw.
39. ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.
40. (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.
41. ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.
42. ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.
43. trial.ti.
44. (assign$ or allocat$).tw.
45. controls.tw.
46. or/26-45
47. 25 and 46
48. exp animals/ not humans.sh.
49. 47 not 48
Appendix 3. Embase Ovid search strategy
1. cerebrovascular disease/ or exp basal ganglion hemorrhage/ or exp brain hematoma/ or exp brain hemorrhage/ or exp brain infarc-
tion/ or exp brain ischemia/ or exp carotid artery disease/ or cerebral artery disease/ or exp cerebrovascular accident/ or exp intracranial
aneurysm/ or exp occlusive cerebrovascular disease/ or stroke unit/ or stroke patient/
2. (stroke$ or poststroke or apoplex$ or cerebral vasc$ or brain vasc$ or cerebrovasc$ or cva$ or SAH).tw.
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3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or middle
cerebral artery or MCA$ or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying) adj5 (isch?
emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or hypoxi$)).tw.
4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraparenchymal or intraventricular or infratentorial
or supratentorial or basal gangli$ or putaminal or putamen or posterior fossa or hemispher$ or subarachnoid) adj5 (h?emorrhag$ or h?
ematoma$ or bleed$)).tw.
5. paralysis/ or hemiparesis/ or hemiplegia/ or paresis/
6. (hemipleg$ or hemipar$ or paresis or paretic).tw.
7. 1 or 2 or 3 or 4 or 5 or 6
8. bed rest/ or immobilization/ or rest/
9. (bed rest or bed-rest or bedrest or bed bound or bed-bound or bedbound).tw.
10. ((confined or restrict$ or immobili$) adj5 bed).tw.
11. mobilization/ or patient mobility/ or physical mobility/
12. exp physiotherapy/ or physiotherapist/ or exp rehabilitation/ or daily life activity/ or convalescence/ or "movement (physiology)"/ or
exp locomotion/ or motor activity/ or exp exercise/ or exp kinesiotherapy/
13. (stroke unit$ or mobility protocol).tw.
14. 11 or 12 or 13
15. early intervention/ or time/ or early.tw.
16. 14 and 15
17. ((early or earlie$ or accelerat$ or immediat$ or fast-track or timing or rapid$) adj5 (mobil$ or ambulat$ or rehab$ or physiotherapy or
physical therapy or physical activity or movement or sitting or standing or walking or semi-recumb$ or out of bed)).tw.
18. 8 or 9 or 10 or 16 or 17
19. 7 and 18
20. *cerebrovascular disease/rh or exp *basal ganglion hemorrhage/rh or exp *brain hematoma/rh or exp *brain hemorrhage/rh or exp
*brain infarction/rh or exp *brain ischemia/rh or exp *carotid artery disease/rh or *cerebral artery disease/rh or exp *cerebrovascular
accident/rh or exp *intracranial aneurysm/rh or exp *occlusive cerebrovascular disease/rh
21. 15 and 20
22. 19 or 21
23. Randomized Controlled Trial/ or "randomized controlled trial (topic)"/
24. Randomization/
25. Controlled clinical trial/ or "controlled clinical trial (topic)"/
26. control group/ or controlled study/
27. clinical trial/ or "clinical trial (topic)"/ or phase 1 clinical trial/ or phase 2 clinical trial/ or phase 3 clinical trial/ or phase 4 clinical trial/
28. Double Blind Procedure/
29. Single Blind Procedure/ or triple blind procedure/
30. (random$ or RCT or RCTs).tw.
31. (controlled adj5 (trial$ or stud$)).tw.
32. (clinical$ adj5 trial$).tw.
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33. ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.
34. (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.
35. ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.
36. ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.
37. trial.ti.
38. (assign$ or allocat$).tw.
39. controls.tw.
40. or/23-39
41. 22 and 40
42. (exp animals/ or exp invertebrate/ or animal experiment/ or animal model/ or animal tissue/ or animal cell/ or nonhuman/) not (human/
or normal human/ or human cell/)
43. 41 not 42
Appendix 4. CINHAL EBSCO search strategy
S1 .(MH "Cerebrovascular Disorders") OR (MH "Basal Ganglia Cerebrovascular Disease+") OR (MH "Carotid Artery Diseases+") OR (MH "Cere-
bral Ischemia+") OR (MH "Cerebral Vasospasm") OR (MH "Intracranial Arterial Diseases+") OR (MH "Intracranial Embolism and Thrombo-
sis") OR (MH "Intracranial Hemorrhage+") OR (MH "Stroke") OR (MH "Vertebral Artery Dissections")
S2 .(MH "Stroke Patients") OR (MH "Stroke Units")
S3 .TI ( stroke* or poststroke or apoplex* or cerebral vasc* or brain vasc* or cerebrovasc* or cva* or SAH ) or AB ( stroke* or poststroke or
apoplex* or cerebral vasc* or brain vasc* or cerebrovasc* or cva* or SAH )
S4 .TI ( brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or supratentorial or
middle cerebral artery or MCA* or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying ) or
AB ( brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or supratentorial or middle
cerebral artery or MCA* or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying )
S5 .TI ( ischemi* or ischaemi* or infarct* or thrombo* or emboli* or occlus* or hypoxi* ) or AB ( ischemi* or ischaemi* or infarct* or thrombo*
or emboli* or occlus* or hypox* )
S6 .S4 and S5
S7 .TI ( brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or infratentorial
or supratentorial or basal gangli* or putaminal or putamen or posterior fossa or hemispher* or subarachnoid ) or AB ( brain* or cerebr* or
cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or infratentorial or supratentorial or basal
gangli* or putaminal or putamen or posterior fossa or hemispher* or subarachnoid )
S8 .TI ( haemorrhage* or hemorrhage* or haematoma* or hematoma* or bleed* ) or AB ( haemorrhage* or hemorrhage* or haematoma*
or hematoma* or bleed* )
S9 .S7 and S8
S10 .(MH "Hemiplegia")
S11 .TI ( hemipleg* or hemipar* or paresis or paretic ) or AB ( hemipleg* or hemipar* or paresis or paretic )
S12 .S1 OR S2 OR S3 OR S6 OR S9 OR S10 OR S11
S13 .(MH "Early Ambulation")
S14 .(MH "Bed Rest") OR (MH "Bed Rest Care (Iowa NIC)") OR (MH "Rest (Iowa NOC)")
S15 .(MH "Immobilization")
S16 .TI ( bed rest or bed-rest or bedrest or bed bound or bed-bound or bedbound) OR AB ( bed rest or bed-rest or bedrest or bed bound
or bed-bound or bedbound)
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S17 .TI ((confined or restricted or immobili*) N5 bed) OR AB ((confined or restricted or immobili*) N5 bed)
S18 .(MH "Physical Mobility") OR (MH "Mobility Therapy (Saba CCC)")
S19 .(MH "Ambulation Aids+") OR (MH "Ambulation Therapy (Saba CCC)") OR (MH "Exercise Therapy: Ambulation (Iowa NIC)") OR (MH
"Ambulation: Walking (Iowa NOC)") OR (MH "Walking+")
S20 .(MH "Activities of Daily Living+") or (MH "Physical Therapy+") or (MH "Rehabilitation") or (MH "Movement+")
S21 .TI ( stroke unit* or mobility protocol ) OR AB ( stroke unit* or mobility protocol )
S22 .S18 OR S19 OR S20 OR S21
S23 .(MH "Time+") OR (MH "Early Intervention") OR TI ( early ) OR AB ( early )
S24 .S22 AND S23
S25 .TI ( (early or earlie* or accelerat* or immediate* or fast-track or timing or rapid) N10 (mobil* or ambulat* or rehab* or physiotherapy
or physical therapy or physical activity or movement or sitting or standing or walking or semi-recumb* or out of bed) ) OR AB ( (early or
earlie* or accelerat* or immediate or fast-track or timing or rapid) N10 (mobil* or ambulat* or rehab* or physiotherapy or physical therapy
or physical activity or movement or sitting or standing or walking or semi-recumb* or out of bed) )
S26 .S13 OR S14 OR S15 OR S16 OR S17 OR S24 OR S25
S27 .S12 AND S26
S28 .(MH "Randomized Controlled Trials") or (MH "Random Assignment") or (MH "Random Sample+")
S29 .(MH "Clinical Trials") or (MH "Intervention Trials") or (MH "Therapeutic Trials")
S30 .(MH "Double-Blind Studies") or (MH "Single-Blind Studies") or (MH "Triple-Blind Studies")
S31 .(MH "Control (Research)") or (MH "Control Group")
S32 .(MH "Quasi-Experimental Studies")
S33 .PT (clinical trial or randomized controlled trial)
S34 .TI (random* or RCT or RCTs) or AB (random* or RCT or RCTs)
S35 .TI (controlled N5 (trial* or stud*)) or AB (controlled N5 (trial* or stud*))
S36 .TI (clinical* N5 trial*) or AB (clinical* N5 trial*)
S37 .TI ((control or treatment or experiment* or intervention) N5 (group* or subject* or patient*)) or AB ((control or treatment or experi-
ment* or intervention) N5 (group* or subject* or patient*))
S38 .TI ((control or experiment* or conservative) N5 (treatment or therapy or procedure or manage*)) or AB ((control or experiment* or
conservative) N5 (treatment or therapy or procedure or manage*))
S39 .TI ((singl* or doubl* or tripl* or trebl*) N5 (blind* or mask*)) or AB ((singl* or doubl* or tripl* or trebl*) N5 (blind* or mask*))
S40 .TI trial
S41 .TI (assign* or allocat*) or AB (assign* or allocat*)
S42 .TI controls or AB controls
S43 .TI (quasi-random* or quasi random* or pseudo-random* or pseudo random*) or AB (quasi-random* or quasi random* or pseudo-ran-
dom* or pseudo random*)
S44 .S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41 OR S42 OR S43
S45 .S27 AND S44
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Appendix 5. PsycINFO Ovid search strategy
1. cerebrovascular disorders/ or cerebral hemorrhage/ or exp cerebral ischemia/ or cerebral small vessel disease/ or cerebrovascular ac-
cidents/ or subarachnoid hemorrhage/
2. (stroke$ or poststroke or apoplex$ or cerebral vasc$ or brain vasc$ or cerebrovasc$ or cva$ or SAH).tw.
3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or middle
cerebral artery or MCA$ or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying) adj5 (isch?
emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or hypoxi$)).tw.
4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraparenchymal or intraventricular or infratentorial
or supratentorial or basal gangli$ or putaminal or putamen or posterior fossa or hemispher$ or subarachnoid) adj5 (h?emorrhag$ or h?
ematoma$ or bleed$)).tw.
5. hemiparesis/ or hemiplegia/
6. (hemipleg$ or hemipar$ or paresis or paretic).tw.
7. or/1-6
8. (bed rest or bed-rest or bedrest or bed bound or bed-bound or bedbound).tw.
9. ((confined or restricted or immobili$) adj5 bed).tw.
10. physical mobility/ or physical therapy/ or physical activity/ or physical therapists/
11. rehabilitation/ or "activities of daily living"/
12. motor processes/ or locomotion/ or walking/
13. exercise/
14. (stroke unit$ or mobility protocol).tw.
15. 10 or 11 or 12 or 13 or 14
16. early intervention/ or time/ or early.tw.
17. 15 and 16
18. ((early or earlie$ or accelerat$ or immediat$ or fast-track or timing or rapid$) adj5 (mobil$ or ambulat$ or rehab$ or physiotherapy or
physical therapy or physical activity or movement or sitting or standing or walking or semi-recumb$ or out of bed)).tw.
19. 8 or 9 or 17 or 18
20. 7 and 19
21. clinical trials/ or treatment effectiveness evaluation/ or placebo/
22. (random$ or RCT or RCTs).tw.
23. (controlled adj5 (trial$ or stud$)).tw.
24. (clinical$ adj5 trial$).tw.
25. ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.
26. (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.
27. ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.
28. ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.
29. trial.ti.
30. (assign$ or allocat$).tw.
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31. controls.tw.
32. or/21-31
33. 20 and 32
Appendix 6. AMED Ovid search strategy
1. cerebrovascular disorders/ or cerebral hemorrhage/ or cerebral infarction/ or cerebral ischemia/ or cerebrovascular accident/ or stroke/
2. (stroke$ or poststroke or apoplex$ or cerebral vasc$ or brain vasc$ or cerebrovasc$ or cva$ or SAH).tw.
3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or middle
cerebral artery or MCA$ or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying) adj5 (isch?
emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or hypoxi$)).tw.
4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraparenchymal or intraventricular or infratentorial
or supratentorial or basal gangli$ or putaminal or putamen or posterior fossa or hemispher$ or subarachnoid) adj5 (h?emorrhag$ or h?
ematoma$ or bleed$)).tw.
5. hemiplegia/ or gait disorders/
6. (hemipleg$ or hemipar$ or paresis or paretic).tw.
7. 1 or 2 or 3 or 4 or 5 or 6
8. bed rest/ or immobilization/ or rest/
9. (bed rest or bed-rest or bedrest or bed bound or bed-bound or bedbound).tw.
10. ((confined or restricted or immobili$) adj5 bed).tw.
11. mobilisation/
12. physical therapy modalities/ or physiotherapists/ or exp exercise therapy/ or rehabilitation/ or exp locomotion/ or movement/ or motor
activity/ or "activities of daily living"/
13. (stroke unit$ or mobility protocol).tw.
14. 11 or 12 or 13
15. time/ or early.tw.
16. 14 and 15
17. ((early or earlie$ or accelerat$ or immediat$ or fast-track or timing or rapid$) adj5 (mobil$ or ambulat$ or rehab$ or physiotherapy or
physical therapy or physical activity or movement or sitting or standing or walking or semi-recumb$ or out of bed)).tw.
18. 8 or 9 or 10 or 16 or 17
19. 7 and 18
20. clinical trials/ or randomized controlled trials/ or random allocation/
21. research design/ or comparative study/
22. double blind method/ or single blind method/
23. (random$ or RCT or RCTs).tw.
24. (controlled adj5 (trial$ or stud$)).tw.
25. (clinical$ adj5 trial$).tw.
26. ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.
27. (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.
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28. ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.
29. ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.
30. trial.ti.
31. (assign$ or allocat$).tw.
32. controls.tw.
33. or/20-32
34. 19 and 33
Appendix 7. SPORTDiscus EBSCO search strategy
S1 .DE "CEREBROVASCULAR disease" OR DE "BRAIN -- Hemorrhage" OR DE "CEREBRAL embolism & thrombosis" OR DE "STROKE" OR DE
"BRAIN -- Wounds & injuries" OR DE "BRAIN damage"
S2 .DE "CEREBROVASCULAR disease -- Patients"
S3 .TI ( stroke* or poststroke or apoplex* or cerebral vasc* or brain vasc* or cerebrovasc* or cva* or SAH ) or AB ( stroke* or poststroke or
apoplex* or cerebral vasc* or brain vasc* or cerebrovasc* or cva* or SAH )
S4 .TI ( brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or supratentorial or
middle cerebral artery or MCA* or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying ) or
AB ( brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or supratentorial or middle
cerebral artery or MCA* or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying )
S5 .TI ( ischemi* or ischaemi* or infarct* or thrombo* or emboli* or occlus* or hypoxi* ) or AB ( ischemi* or ischaemi* or infarct* or thrombo*
or emboli* or occlus* or hypox* )
S6 .S4 and S5
S7 .TI ( brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or infratentorial
or supratentorial or basal gangli* or putaminal or putamen or posterior fossa or hemispher* or subarachnoid ) or AB ( brain* or cerebr* or
cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or infratentorial or supratentorial or basal
gangli* or putaminal or putamen or posterior fossa or hemispher* or subarachnoid )
S8 .TI ( haemorrhage* or hemorrhage* or haematoma* or hematoma* or bleed* ) or AB ( haemorrhage* or hemorrhage* or haematoma*
or hematoma* or bleed* )
S9 .S7 and S8
S10 .DE "HEMIPLEGIA" OR DE "HEMIPLEGICS" OR DE "GAIT disorders"
S11 .TI ( hemipleg* or hemipar* or paresis or paretic ) or AB ( hemipleg* or hemipar* or paresis or paretic )
S12 .S1 OR S2 OR S3 OR S6 OR S9 OR S10 OR S11
S13 .DE "REST" OR DE "IMMOBILIZATION (Therapeutics)"
S14 .TI ( bed rest or bed-rest or bedrest or bed bound or bed-bound or bedbound) OR AB ( bed rest or bed-rest or bedrest or bed bound
or bed-bound or bedbound)
S15 .TI ((confined or restricted or immobili*) N5 bed) OR AB ((confined or restricted or immobili*) N5 bed)
S16 .DE "PHYSICAL activity” OR DE "PHYSICAL therapists"
S17 .DE "REHABILITATION" OR DE "MEDICAL rehabilitation" OR DE "RECOVERY training" OR DE "MOVEMENT therapy"
S18 .DE "ACTIVITIES of daily living training" OR DE "ACTIVITIES of daily living" OR DE "FUNCTIONAL training"
S19 .DE "BODY movement" OR DE "MOVEMENT therapy" OR DE "LOCOMOTION" OR DE "WALKING" OR DE "EXERCISE" OR DE "ARM exer-
cises" OR DE "CHAIR exercises" OR DE "LEG exercises" OR DE "STRENGTH training" OR DE "STRETCHING exercises"
S20 .DE "EXERCISE therapy"
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S21 .TI ( stroke unit* or mobility protocol ) OR AB ( stroke unit* or mobility protocol )
S22 .S16 OR S17 OR S18 OR S19 OR S20 OR S21
S23 .TI ( early ) OR AB ( early )
S24 .S22 AND S23
S25 .TI ( (early or earlie* or accelerat* or immediat* or fast-track or timing or rapid) N10 (mobil* or ambulat* or rehab* or physiotherapy
or physical therapy or physical activity or movement or sitting or standing or walking or semi-recumb* or out of bed) ) OR AB ( (early or
earlie* or accelerat* or immediate or fast-track or timing or rapid) N10 (mobil* or ambulat* or rehab* or physiotherapy or physical therapy
or physical activity or movement or sitting or standing or walking or semi-recumb* or out of bed) )
S26 .S13 OR S14 OR S15 OR S24 OR S25
S27 .S12 AND S26
Appendix 8. Web of Science search strategy
Web of Science: Core Collection 1900-2016 (Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), and
Arts & Humanities Citation Index (A&HCI)).
# 26. #25 AND #12 AND #6 (Indexes=SCI-EXPANDED, SSCI, A&HCI Timespan=2006-2016)
# 25. #24 OR #23 OR #22 OR #21 OR #20 OR #19 OR #18 OR #17 OR #16 OR #15 OR #14 OR #13
# 24. TS=controls
# 23. TS=(assign* or allocat*)
# 22. TI=trial
# 21. TS=(placebo* or sham)
# 20. TS=(cross-over or cross over or crossover)
# 19 .TS=((singl* or doubl* or tripl* or trebl*) NEAR/5 (blind* or mask*))
# 18. TS=((control or experiment* or conservative) NEAR/5 (treatment or therapy or procedure or manage*))
# 17. TS=(quasi-random* or quasi random* or pseudo-random* or pseudo random*)
# 16. TS=((control or treatment or experiment* or intervention) NEAR/5 (group* or subject* or patient*))
# 15. TS=(clinical* NEAR/5 trial*)
# 14. TS=(controlled NEAR/5 (trial* or stud*))
# 13. TS=(random* or RCT or RCTs)
# 12. #7 OR #8 OR #11
# 11. #9 AND #10
# 10. TS=(mobil* or ambulat* or rehab* or physiotherapy or physical therapy or physical activity or movement or sitting or standing or
walking or semi-recumb* or out of bed)
# 9. TS=(early or earlie* or accelerat* or immediat* or fast-track or timing or rapid*)
# 8. TS=((confined or restricted or immobili*) NEAR/5 bed).
# 7. TS=(bed rest or bed-rest or bedrest or bed bound or bed-bound or bedbound).
# 6. #5 OR #4 OR #3 OR #2 OR #1
# 5. TS=((unilateral or spatial or hemi$spatial or visual) NEAR/5 neglect)
# 4. TS=(hemipleg* or hemipar* or paresis or paretic or hemineglect or hemi-neglect)
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# 3. TS=((brain* or cerebr* or cerebell* or intracerebral or intracranial or subarachnoid) NEAR/5 (haemorrhage* or hemorrhage* or
haematoma* or hematoma* or bleed*))
# 2. TS=((brain* or cerebr* or cerebell* or intracran* or intracerebral) NEAR/5 (isch$emi* or infarct* or thrombo* or emboli* or occlus*))
# 1. TS=(stroke or poststroke or post-stroke or cerebrovasc* or brain vasc* or cerebral vasc* or cva* or apoplex* or SAH)
W H A T ' S   N E W
 
Date Event Description
14 March 2018 New search has been performed Updated literature search with no new completed trials identi-
fied. The review now includes nine RCTs (2958 participants). Text
revised and exploratory network meta-analysis added.
14 March 2018 New citation required but conclusions
have not changed
No change to the conclusions.
 
H I S T O R Y
Protocol first published: Issue 4, 2006
Review first published: Issue 1, 2009
 
Date Event Description
5 May 2008 Amended Converted to new review format.
 
C O N T R I B U T I O N S   O F   A U T H O R S
For this review update, Peter Langhorne co-ordinated the updated searches, drafted the update, and re-drafted in response to comments.
Peter Langhorne and Trish Bate extracted references. Julie Bernhardt, Janice Collier, Matthew Thuy, and Trish Bate refined the manuscript.
For the original review, Julie Bernhardt drafted the protocol and participated in all stages of the review. Janice Collier and Lynn Legg
refined the protocol and contributed to the planned bibliographic searches. Matthew Thuy and Lynn Legg identified studies, assessed
methodological quality, and checked the extracted data. Matthew Thuy performed much of the planned bibliographic searches, obtained
full-text articles and made contact with study authors. All review authors commented on dra&s of the manuscript.
D E C L A R A T I O N S   O F   I N T E R E S T
Several of the review authors were trialists in at least one of the included trials. However, we allocated trial selection decisions in a manner
that avoided trialists making decisions about their own trials.
Peter Langhorne: PL is trialist in two of the included trials (AVERT III 2015; Langhorne 2010). However, trial selection decisions were allo-
cated in a manner to avoid making decisions about his own trials.
Janice M Collier: JC is trialist in two of the included trials (AVERT II 2008; AVERT III 2015). However, trial selection decisions were allocated
in a manner to avoid making decisions about her own trials.
Patricia J Bate: none known
Matthew NT Thuy: none known
Julie Bernhardt: JB is trialists in three of the included trials (AVERT II 2008; AVERT III 2015; Langhorne 2010). However, trial selection deci-
sions were allocated in a manner to avoid making decisions about her own trials.
S O U R C E S   O F   S U P P O R T
Internal sources• No sources of support supplied
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External sources• NIHR Priority Review Support Programme, UK.
D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
We added, or more explicitly defined, the following secondary outcomes:
• Death or requiring institutional care: we defined institutional care as care within a residential home, nursing home, or hospital at fol-
low-up.• Type of complication (adverse events): categorised as complications of immobility (deep vein thrombosis (DVT), pulmonary embolism
(PE), incidence and grade of pressure sores (using standardized grading scale), chest infection, urinary tract infection, falls), and other
complications.• 'Time to walking unassisted (without help from another person) reported alone or as a component of a functional mobility scale' has
been replaced by 'Able to walk (Outcome 1.8) and mobility score (Outcome 1.9)'. This minor change was to allow the inclusion of more
trial data.• 'Length of acute stay in acute hospital (Outcome 1.13)' was added to provide an indicator of resource use.
Search Strategy: the WHO Registry now incorporates the Australian Clinical Trials Registry (ACTR; now the Australian New Zealand Clinical
Trials Registry (ANZCTR)), the Netherlands Trial Register, and ISRCTNs data sets.
Network meta-analysis: we included an exploratory network meta-analysis in view of the diversity of the included studies.
I N D E X   T E R M S
Medical Subject Headings (MeSH)
*Early Ambulation  [adverse eHects]  [mortality];  *Stroke Rehabilitation  [mortality];  Activities of Daily Living;  Length of Stay;  Network
Meta-Analysis;  Quality of Life;  Randomized Controlled Trials as Topic;  Time Factors
MeSH check words
Adult; Humans
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